BIO-key International (BKYI) 10-K 31 Mar 15 2014 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Mar. 25, 2015	Jun. 30, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	BIO KEY INTERNATIONAL INC
Document Type	10-K
Current Fiscal Year End Date	-19
Entity Common Stock, Shares Outstanding		66,001,260
Entity Public Float			$28,161,078
Amendment Flag	FALSE
Entity Central Index Key	1019034
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Document Period End Date	31-Dec-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
ASSETS
Cash and cash equivalents	$843,632	$2,023,349
Accounts receivable, net	625,341	284,025
Due from factor	76,657	2,449
Inventory	11,825	9,376
Prepaid expenses and other	236,429	73,482
Total current assets	1,793,884	2,392,681
Equipment and leasehold improvements, net	103,509	125,062
Deposits and other assets	8,712	8,712
Intangible assets—less accumulated amortization	161,344	174,950
Total non-current assets	273,565	308,724
TOTAL ASSETS	2,067,449	2,701,405
LIABILITIES
Accounts payable	347,311	540,912
Accrued liabilities	488,617	338,321
Deferred revenue	429,233	528,160
Warrant liabilities	43,227
Total current liabilities	1,308,388	1,407,393
Warrant liabilities		243,077
TOTAL LIABILITIES	1,308,388	1,650,470
Commitments and Contingencies
STOCKHOLDERS’ EQUITY
Common stock — authorized, 170,000,000 shares; issued and outstanding; 66,001,260 and 57,921,258 of $.0001 par value at December 31, 2014 and December 31, 2013, respectively	6,600	5,792
Additional paid-in capital	57,506,605	55,915,715
Accumulated deficit	-56,754,144	-54,870,572
TOTAL STOCKHOLDERS’ EQUITY	759,061	1,050,935
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$2,067,449	$2,701,405

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parentheticals) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Common stock, shares authorized	170,000,000	170,000,000
Common stock, shares issued	66,001,260	57,921,258
Common stock, shares outstanding	66,001,260	57,921,258
Common stock, par value (in Dollars per share)	$0.00	$0.00

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Revenues
Services	$1,489,820	$988,003
License fees and other	2,516,036	997,973
	4,005,856	1,985,976
Costs and other expenses
Cost of services	445,803	145,702
Cost of license fees and other	302,947	241,326
	748,750	387,028
Gross Profit	3,257,106	1,598,948
Operating expenses
Selling, general and administrative	3,670,090	2,776,559
Research, development and engineering	1,626,136	1,344,070
	5,296,226	4,120,629
Operating loss	-2,039,120	-2,521,681
Other income (deductions)
Interest income	7	7
Interest expense		-136,484
Gain on derivative liabilities	157,253	78,812
Income taxes	-1,712	-2,805
	155,548	-60,470
Net loss	($1,883,572)	($2,582,151)
Basic and Diluted Loss per Common Share (in Dollars per share)	($0.03)	($0.06)
Weighted Average Shares Outstanding:
Basic and Diluted (in Shares)	59,047,282	45,895,946

Consolidated_Statements_of_Sto

Consolidated Statements of Stockholders' Equity (Deficit) (USD $)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2012	$3,907	$51,066,532	($52,288,421)	($1,217,982)
Shares (in Shares) at Dec. 31, 2012	39,077,807
Derivative liabilities associated with security purchase agreements		-346,214		-346,214
Stock issuance costs		-648,116		-648,116
Share-based compensation		81,642		81,642
Reclassification of derivative liability		113,962		113,962
Net loss			-2,582,151	-2,582,151
Issuance of common stock and warrants pursuant to security purchase agreements	1,859	5,647,935		5,649,794
Issuance of common stock and warrants pursuant to security purchase agreements (in Shares)	18,587,139
Issuance of common stock pursuant to anti-dilution rights	21	-21
Issuance of common stock pursuant to anti-dilution rights (in Shares)	206,033
Issuance of common stock in exchange for options exercised	5	-5
Issuance of common stock in exchange for options exercised (in Shares)	50,279			89,999
Balance at Dec. 31, 2013	5,792	55,915,715	-54,870,572	1,050,935
Shares (in Shares) at Dec. 31, 2013	57,921,258
Stock issuance costs		-103,157		-103,157
Share-based compensation		207,258		207,258
Reclassification of derivative liability		42,597		42,597
Net loss			-1,883,572	-1,883,572
Issuance of common stock and warrants pursuant to security purchase agreements	797	1,594,203		1,595,000
Issuance of common stock and warrants pursuant to security purchase agreements (in Shares)	7,974,999
Issuance of common stock in exchange for cashless exercise of warrants	8	-8
Issuance of common stock in exchange for cashless exercise of warrants (in Shares)	76,830
Issuance of common stock in exchange for options exercised	3	-3
Issuance of common stock in exchange for options exercised (in Shares)	28,173			54,166
Repurchase of warrants		-150,000		-150,000
Balance at Dec. 31, 2014	$6,600	$57,506,605	($56,754,144)	$759,061
Shares (in Shares) at Dec. 31, 2014	66,001,260

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
CASH FLOW FROM OPERATING ACTIVITIES:
Net loss	($1,883,572)	($2,582,151)
Adjustments to reconcile net loss to cash used for operating activities:
Depreciation	40,186	28,618
Intangible assets	13,606	20,961
Deferred costs		107,203
Share-based compensation	207,258	81,642
Gain on derivative liabilities	-157,253	-78,812
Change in assets and liabilities:
Accounts receivable trade	-341,316	320,759
Due from factor	-74,208	187,455
Inventory	-2,449	-5,190
Prepaid expenses and other	-162,947	-48,394
Accounts payable	-193,601	-480,364
Accrued liabilities	150,296	-255,278
Deferred revenue	-98,927	19,640
Net cash used for operating activities	-2,502,927	-2,683,911
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures	-18,633	-129,413
Net cash used for investing activities	-18,633	-129,413
CASH FLOW FROM FINANCING ACTIVITIES:
Issuances of common stock	1,595,000	5,649,793
Repurchase of outstanding warrants	-150,000
Costs to issue common stock and Note Payable	-103,157	-575,681
Repayment of notes payable – related party		-321,428
Proceeds from issuance of Note Payable		497,307
Repayment of Note Payable		-497,307
Net cash provided by financing activities	1,341,843	4,752,684
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	-1,179,717	1,939,360
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR	2,023,349	83,989
CASH AND CASH EQUIVALENTS, END OF YEAR	843,632	2,023,349
Cash paid for:
Interest		77,216
Reclassification of derivative liability to additional paid-in capital	42,597	113,962
Issuance of warrants for deferred financing costs and equity raise		89,637
Unpaid costs to issue common stock		$90,000

Note_A_The_Company_and_Summary

Note A - The Company and Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2014

Disclosure Text Block [Abstract]

Business Description and Accounting Policies [Text Block]

NOTE A —THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Business

The Company, founded in 1993, develops and markets proprietary fingerprint identification biometric technology and software solutions. The Company also deliver advanced identification solutions and information services to law enforcement departments, public safety agencies and other government and private sector customers. Our mobile wireless technology provides first responders with critical, reliable, real-time data and images from local, state and national databases.

Basis of Presentation

The Company has incurred significant losses to date, and at December 31, 2014, it had an accumulated deficit of approximately $57 million. In addition, broad commercial acceptance of the Company’s technology is critical to the Company’s success and ability to generate future revenues. At December 31, 2014, our total cash and cash equivalents were approximately $844,000, as compared to approximately $2,023,000 at December 31, 2013.

As discussed below, the Company has financed itself in the past through access to the capital markets by issuing secured and convertible debt securities, convertible preferred stock, common stock, and recently through factoring receivables. The Company currently requires approximately $475,000 per month to conduct operations, a monthly amount that it has been unable to achieve through revenue generation.

If the Company is unable to generate sufficient revenue to meet our goals, it will need to obtain additional third-party financing to (i) conduct the sales, marketing and technical support necessary to execute its plan to substantially grow operations, increase revenue and serve a significant customer base; and (ii) provide working capital. No assurance can be given that any form of additional financing will be available on terms acceptable to the Company, that adequate financing will be obtained by the Company in order to meet its needs, or that such financing would not be dilutive to existing shareholders.

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP"), which contemplate continuation of the Company as a going concern, and assumes continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The matters described in the preceding paragraphs raise substantial doubt about the Company’s ability to continue as a going concern. Recoverability of a major portion of the recorded asset amounts shown in the accompanying balance sheet is dependent upon the Company’s ability to meet its financing requirements on a continuing basis, and become profitable in its future operations. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.

Effective February 3, 2015, the Company implemented a reverse stock split of its outstanding common stock at a ratio of 1 - for - 2 shares. All share figures and results are reflected on a post-split basis. See Note L.

Summary of Significant Accounting Policies

A summary of the significant accounting policies consistently applied in the preparation of the accompanying consolidated financial statements follows:

1.  Basis of Consolidation

The accompanying consolidated financial statements include the accounts of BIO-key International, Inc. and its wholly-owned subsidiary (collectively, the “Company”). Intercompany accounts and transactions have been eliminated in consolidation.

2. Use of Estimates

Our consolidated financial statements are prepared in accordance with GAAP as set forth in the Financial Accounting Standards Board’s (FASB) Accounting Standards Codification (ASC) and consider the various staff accounting bulletins and other applicable guidance issued by the U.S. Securities and Exchange Commission (SEC). These accounting principles require us to make certain estimates, judgments and assumptions. The Company believes that the estimates, judgments and assumptions upon which it relies are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. To the extent there are material differences between these estimates, judgments or assumptions and actual results, its consolidated financial statements will be affected. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management’s judgment in its application. There are also areas in which management’s judgment in selecting among available alternatives would not produce a materially different result.

3. Revenue Recognition

Revenues from software licensing are recognized in accordance with ASC 985-605, "Software Revenue Recognition." Accordingly, revenue from software licensing is recognized when all of the following criteria are met: persuasive evidence of an arrangement exists, delivery has occurred, the fee is fixed or determinable, and collectability is probable.

The Company intends to enter into arrangements with end users for items which may include software license fees, and services or various combinations thereof. For each arrangement, revenues will be recognized when evidence of an agreement has been documented, the fees are fixed or determinable, collection of fees is probable, delivery of the product has occurred and no other significant obligations remain.

Multiple-Element Arrangements: For multiple-element arrangements, the Company applies the residual method in accordance with ASC 985-605. The residual method requires that the portion of the total arrangement fee attributable to the undelivered elements be deferred based on its vendor-specific objective evidence ("VSOE") of fair value and subsequently recognized as the service is delivered. The difference between the total arrangement fee and the amount deferred for the undelivered elements is recognized as revenue related to the delivered elements, which is generally the software license. VSOE of fair value for all elements in an arrangement is based upon the normal pricing for those products and services when sold separately. VSOE of fair value for support services is additionally determined by the renewal rate in customer contracts. The Company has established VSOE of fair value for support as well as consulting services.

License Revenues: Amounts allocated to license revenues are recognized at the time of delivery of the software and all other revenue recognition criteria discussed above have been met.

Revenue from licensing software, which requires significant customization and modification, is recognized using the percentage of completion method, based on the hours of effort incurred by the Company in relation to the total estimated hours to complete. In instances where third party hardware, software or services form a significant portion of a customer’s contract, the Company recognizes revenue for the element of software customization by the percentage of completion method described above. Otherwise, third party hardware, software, and services are recognized upon shipment or acceptance as appropriate. If the Company makes different judgments or utilizes different estimates of the total amount of work expected to be required to customize or modify the software, the timing and revenue recognition, from period to period, and the margins on the project in the reporting period, may differ materially from amounts reported. Anticipated contract losses are recognized as soon as they become known and are estimable.

Service Revenues: Revenues from services are comprised of maintenance and consulting and implementation services. Maintenance revenues include providing for unspecified when-and-if available product updates and customer telephone support services, and are recognized ratably over the term of the service period. Consulting services are generally sold on a time-and-materials basis and include a range of services including installation of software and assisting in the design of interfaces to allow the software to operate in customized environments. Services are generally separable from other elements under the arrangement since performance of the services are not essential to the functionality of any other element of the transaction and are described in the contract such that the total price of the arrangement would be expected to vary as the result of the inclusion or exclusion of the services. Revenues from services are generally recognized as the services are performed.

The Company provides customers, free of charge or at a minimal cost, testing kits which potential licensing customers may use to test compatibility/acceptance of the Company’s technology with the customer’s intended applications.

Costs and other expenses: Includes professional compensation and other direct contract expenses, as well as costs attributable to the support of client service professional staff, depreciation and amortization costs related to assets used in revenue-generating activities, and other costs attributable to serving the Company’s client base. Professional compensation consists of payroll costs and related benefits including stock-based compensation and bonuses. Other direct contract expenses include costs directly attributable to client engagements, such as out-of-pocket costs including travel and subsistence for client service professional staff, costs of hardware and software and costs of subcontractors. The allocation of lease and facilities charges for occupied offices is included in costs of service.

The Company accounts for its warranties under the FASB ASC 450, “Contingencies.” The Company generally warrants that its products are free from defects in material and workmanship for a period of one year from the date of initial receipt by its customers. The warranty does not cover any losses or damage that occurs as a result of improper installation, misuse or neglect or repair or modification by anyone other than the Company or its authorized repair agent. The Company’s policy is to accrue anticipated warranty costs based upon historical percentages of items returned for repair within one year of the initial sale. The Company’s repair rate of products under warranty has been minimal, and a historical percentage has not been established. The Company’s software license agreements generally include certain provisions for indemnifying customers against liabilities if the Company’s software products infringe upon a third party’s intellectual property rights. The Company has not provided for any reserves for warranty liabilities as it was determined to be immaterial.

4.  Cash Equivalents

Cash equivalents consist of liquid investments with original maturities of three months or less.  At December 31, 2014 and 2013, cash equivalents consisted of a money market account.

5. Accounts Receivable

Accounts receivable are carried at original amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on a monthly basis. Management determines the allowance for doubtful receivables by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history, and current economic conditions. Accounts receivable are written off when deemed uncollectible. Recoveries of accounts receivable previously written off are recorded when received. Accounts receivable at December 31, 2014 and 2013 consisted of the following:

December 31,

2014

2013

Accounts receivable

$

645,867

$

304,551

Allowance for doubtful accounts

(20,526

)

(20,526

)

Accounts receivable, net allowances for doubtful accounts

$

625,341

$

284,025

The allowance for doubtful accounts for the years ended December 31, 2014 and 2013 is as follows:

Balance at

Charged to Costs

Deductions From

Balance at

Beginning of Year

and Expenses

Reserves

End of Year

Year Ended December 31, 2014

Allowance for Doubtful Accounts

$

20,526

$

-

$

-

$

20,526

Year Ended December 31, 2013

Allowance for Doubtful Accounts

$

20,526

$

-

$

-

$

20,526

6. Equipment and Leasehold Improvements, Intangible Assets and Depreciation and Amortization

Equipment and leasehold improvements are stated at cost.  Depreciation is provided for in amounts sufficient to relate the cost of depreciable assets to operations over the estimated service lives, principally using straight-line methods. Leasehold improvements are amortized over the shorter of the life of the improvement or the lease term, using the straight-line method.

The estimated useful lives used to compute depreciation and amortization for financial reporting purposes are as follows:

2014

Equipment and leasehold improvements

Equipment (years)

3

-

5

Furniture and fixtures (years)

3

-

5

Software (years)

3

Leasehold improvements

life or lease term

Intangible assets consist of patents.  Patent costs are capitalized until patents are awarded. Upon award, such costs are amortized using the straight-line method over their respective economic lives. If a patent is denied, all costs are charged to operations in that year.

7. Impairment or Disposal of Long Lived Assets, including Intangible Assets

The Company reviews long-lived assets, including intangible assets subject to amortization, whenever events or changes in circumstances indicate that the carrying amount of such an asset may not be recoverable. Recoverability of these assets is measured by comparison of their carrying amount to the future undiscounted cash flows the assets are expected to generate. If such assets are considered impaired, the impairment to be recognized is equal to the amount by which the carrying value of the assets exceeds their fair value determined by either a quoted market price, if any, or a value determined by utilizing a discounted cash flow technique. In assessing recoverability, the Company must make assumptions regarding estimated future cash flows and discount factors. If these estimates or related assumptions change in the future, the Company may be required to record impairment charges. Intangible assets with determinable lives are amortized over their estimated useful lives, based upon the pattern in which the expected benefits will be realized, or on a straight-line basis, whichever is greater. We did not record any impairment charges in any of the years presented.

8. Advertising Expense

The Company expenses the costs of advertising as incurred. Advertising expenses for 2014 and 2013 were approximately $252,000 and $178,000, respectively.

9. Deferred Revenue

Deferred revenue includes customer advances and amounts that have been billed per the contractual terms but have not been recognized as revenue. The majority of these amounts are related to maintenance contracts for which the revenue is recognized ratably over the applicable term, which generally is 12 months from the date the customer is delivered the products.

10. Research and Development Expenditures

Research and development expenses include costs directly attributable to the conduct of research and development programs primarily related to the development of our software products and improving the efficiency and capabilities of our existing software. Such costs include salaries, payroll taxes, employee benefit costs, materials, supplies, depreciation on research equipment, services provided by outside contractors, and the allocable portions of facility costs, such as rent, utilities, insurance, repairs and maintenance, depreciation and general support services. All costs associated with research and development are expensed as incurred.

11. Earnings Per Share of Common Stock (“EPS”)

The Company’s EPS is calculated by dividing net income (loss) applicable to common stockholders by the weighted-average number of common shares outstanding during the reporting period. Diluted EPS includes the effect from potential issuances of common stock, such as stock issuable pursuant to the exercise of stock options and warrants, when the effect of their inclusion is dilutive. See Note P - Earnings Per Share “EPS” for additional information.

12. Accounting for Stock-Based Compensation

The Company accounts for share based compensation in accordance with the provisions of ASC 718-10, “Compensation — Stock Compensation,” which requires measurement of compensation cost for all stock awards at fair value on date of grant and recognition of compensation over the service period for awards expected to vest. The majority of its share-based compensation arrangements vest over either a three or four year vesting schedule. The Company expenses its share-based compensation under the ratable method, which treats each vesting tranche as if it were an individual grant. The fair value of stock options is determined using the Black-Scholes valuation model, and requires the input of highly subjective assumptions. These assumptions include estimating the length of time employees will retain their vested stock options before exercising them (the “expected option term”), the estimated volatility of its common stock price over the option’s expected term, the risk-free interest rate over the option’s expected term, and the Company’s expected annual dividend yield. Changes in these subjective assumptions can materially affect the estimate of fair value of stock-based compensation and consequently, the related amount recognized as an expense in the consolidated statements of operations. As required under the accounting rules, the Company reviews its valuation assumptions at each grant date and, as a result, the Company is likely to change its valuation assumptions used to value employee stock-based awards granted in future periods. The values derived from using the Black-Scholes model are recognized as expense over the service period, net of estimated forfeitures (the number of individuals that will ultimately not complete their vesting requirements). The estimation of stock awards that will ultimately vest requires significant judgment. The Company considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical experience. Actual results, and future changes in estimates, may differ substantially from current estimates.

The compensation expense recognized under ASC 718 amounted to $207,258 and $81,642 for 2014 and 2013 respectively.

The following table presents share-based compensation expenses included in the Company’s consolidated statements of operations:

Year ended

December 31,

2014

2013

Selling, general and administrative

$

161,466

$

60,151

Research, development and engineering

45,792

21,491

$

207,258

$

81,642

Valuation Assumptions for Stock Options

For 2014 and 2013, 1,835,000 and 1,175,000 stock options were granted, respectively. The fair value of each option was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Year ended

December 31,

2014

2013

Risk free interest rate

1.34

%

0.68

%

Expected life of options (in years)

4.5

4.5

Expected dividends

0

%

0

%

Volatility of stock price

119

%

139

%

The stock volatility for each grant is determined based on the review of the experience of the weighted average of historical daily price changes of the Company’s common stock over the expected option term. The expected term was determined using the simplified method for estimating expected option life, which qualify as “plain-vanilla” options; and the risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected life of the option.

13. Derivative Liabilities

In connection with the issuances of equity instruments or debt, the Company may issue options or warrants to purchase common stock. In certain circumstances, these options or warrants may be classified as liabilities, rather than as equity. In addition, the equity instrument or debt may contain embedded derivative instruments, such as conversion options or listing requirements, which in certain circumstances may be required to be bifurcated from the associated host instrument and accounted for separately as a derivative liability instrument. The Company accounts for derivative liability instruments under the provisions of FASB ASC 815, “Derivatives and Hedging.”

14. Deferred Costs

Costs incurred with obtaining and executing debt arrangements are capitalized and amortized to interest expense using the effective interest method over the term of the related debt.

15. Income Taxes

The provision for, or benefit from, income taxes includes deferred taxes resulting from the temporary differences in income for financial and tax purposes using the liability method. Such temporary differences result primarily from the differences in the carrying value of assets and liabilities. Future realization of deferred income tax assets requires sufficient taxable income within the carryback, carryforward period available under tax law. The Company evaluates, on a quarterly basis whether, based on all available evidence, if it is probable that the deferred income tax assets are realizable. Valuation allowances are established when it is more likely than not that the tax benefit of the deferred tax asset will not be realized. The evaluation, as prescribed by ASC 740-10, “Income Taxes,” includes the consideration of all available evidence, both positive and negative, regarding historical operating results including recent years with reported losses, the estimated timing of future reversals of existing taxable temporary differences, estimated future taxable income exclusive of reversing temporary differences and carryforwards, and potential tax planning strategies which may be employed to prevent an operating loss or tax credit carryforward from expiring unused. Because of the Company’s historical performance and estimated future taxable income, a full valuation allowance has been established.

The Company accounts for uncertain tax provisions in accordance with ASC 740-10-05, “Accounting for Uncertainty in Income Taxes.” The ASC clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements. The ASC prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The ASC provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.

16. Recent Accounting Pronouncements

Effective January 1, 2014, the Company adopted Accounting Standards Update (“ASU”) No. 2013-11, “Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists” (“ASU 2013-11”). ASU 2013-11 is expected to reduce diversity in practice by providing guidance on the presentation of unrecognized tax benefits and will better reflect the manner in which an entity would settle at the reporting date any additional income taxes that would result from the disallowance of a tax position when net operating loss carryforwards, similar tax losses, or tax credit carryforwards exist. The amendments in this update should be applied prospectively for annual and interim periods beginning after December 15, 2013. The adoption of ASU 2013-11 did not have a material effect on its consolidated financial statements.

In May 2014, ASU No. 2014-09, “Revenue from Contracts with Customers” was issued. The comprehensive new standard will supersede existing revenue recognition guidance and require revenue to be recognized when promised goods or services are transferred to customers in amounts that reflect the consideration to which the Company expects to be entitled in exchange for those goods or services. The guidance will also require that certain contract costs incurred to obtain or fulfill a contract, such as sales commissions, be capitalized as an asset and amortized as revenue is recognized. Adoption of the new rules could affect the timing of both revenue recognition and the incurrence of contract costs for certain transactions. The guidance permits two implementation approaches, one requiring retrospective application of the new standard with restatement of prior years and one requiring prospective application of the new standard with disclosure of results under old standards. The new standard is effective for reporting periods beginning after December 15, 2016 and early adoption is not permitted. For us, the new standard will be effective January 1, 2017. The Company is currently evaluating the impact of adoption and the implementation approach to be used.

In June 2014, ASU 2014-12, “Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period” (“ASU No. 2014-12”) was issued.  ASU No. 2014-12 requires that a performance target that affects vesting and that could be achieved after the requisite service period is treated as a performance condition. An entity should recognize compensation cost in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the periods for which the requisite service has already been rendered. If the performance target becomes probable of being achieved before the end of the requisite service period, the remaining unrecognized compensation cost should be recognized prospectively over the remaining requisite service period. The total amount of compensation cost recognized during and after the requisite service period should reflect the number of awards that are expected to vest and should be adjusted to reflect those awards that ultimately vest. ASU 2014-12 becomes effective for interim and annual periods beginning on or after December 15, 2015. Early adoption is permitted.  The Company is currently evaluating the effects of adopting ASU 2014-12 on its consolidated financial statements but the adoption is not expected to have a significant impact.

In June 2014, ASU 2014-15, “Presentation of Financial Statements – Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU No. 2014-15”) was issued.  Before the issuance of ASU 2014-15, there was no guidance in U.S. GAAP about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern or to provide related footnote disclosures. This guidance is expected to reduce the diversity in the timing and content of footnote disclosures. ASU 2014-15 requires management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards as specified in the guidance. ASU 2014-15 becomes effective for the annual period ending after December 15, 2016 and for annual and interim periods thereafter. Early adoption is permitted. The Company is currently evaluating the effects of adopting ASU 2014-15 on its consolidated financial statements but the adoption is not expected to have a significant impact.

In January 2015, ASU No. 2015-01, “Income Statement – Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary items” (“ASU 2015-01”) was issued. ASU 2015-01 eliminates from GAAP the concept of extraordinary items. ASU 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. A reporting entity may apply the amendments prospectively. A reporting entity also may apply the amendments retrospectively to all prior periods presented in the financial statements. Early adoption is permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. The Company is currently evaluating the effects of adopting ASU 2014-15 on its consolidated financial statements but the adoption is not expected to have a significant impact.

Management does not believe that any other recently issued, but not yet effective, accounting standard if currently adopted would have a material effect on the accompanying consolidated financial statements.

Note_B_Factoring

Note B - Factoring	12 Months Ended
	Dec. 31, 2014
Factoring [Abstract]
Factoring [Text Block]	NOTE B—FACTORING
	Due from factor consisted of the following as of December 31:
		Original Invoice		Factored		Factored
		Value		Amount		Balance due
	Year Ended December 31, 2014
	Factored accounts receivable	$	306,625	$	229,968	$	76,657
	Year Ended December 31, 2013
	Factored accounts receivable	$	9,795	$	7,346	$	2,449
	As of December 2011, the Company entered into a 24 month accounts receivable factoring arrangement with a financial institution (the “Factor”). Pursuant to the terms of the arrangement, the Company, from time to time, sells to the Factor certain of its accounts receivable balances on a non-recourse basis for credit approved accounts. The Factor remits 75% of the accounts receivable balance to the Company (the “Advance Amount”), with the remaining balance, less fees to be forwarded to the Company once the Factor collects the full accounts receivable balance from the customer. Factoring fees range from 2.75% to 15% of the face value of the invoice factored, and are determined by the number of days required for collection of the invoice. In April 2012, the terms were updated from monthly to quarterly, and the 24-month arrangement was extended to August 1, 2014.  In July of 2014, the arrangement was extended to July 31, 2016.

Note_C_Fair_Values_of_Financia

Note C - Fair Values of Financial Instruments	12 Months Ended
	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Fair Value Disclosures [Text Block]	NOTE C—FAIR VALUES OF FINANCIAL INSTRUMENTS
	Cash and cash equivalents, accounts receivable, due from factor, accounts payable and accrued liabilities are carried at, or approximate, fair value because of their short-term nature.
	The fair value of the warrant liabilities are measured at fair value using the following assumptions:
		2014
	Risk free interest rate	0.59%	-	0.61%
	Expected term	1.82	-	1.86
	Expected dividends		0
	Volatility of stock price	79.30%	-	79.70%
	For the anti-dilution features, the Company utilized the Monte Carlo simulation. The stock volatility for each grant is determined based on the review of the experience of the weighted average of historical daily price changes of the Company’s common stock over the expected term and the risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected term of the derivative.
	The warrant liabilities are considered Level 3 liabilities on the fair value hierarchy as the determination of fair value includes various assumptions about of future activities and the Company’s stock prices and historical volatility as inputs.
	The table below provides a reconciliation of the beginning and ending balances for the liabilities measured at fair value using significant unobservable inputs (Level 3). There were no assets as of or during the years ended December 31, 2014 and 2013 measured using significant unobservable inputs.
	Fair Value Measurements Using
	Significant Unobservable Inputs (Level 3):
	Compensatory Warrant (Note L3)
		Fair value at January 1, 2014			36,370
		Loss on derivative			6,227
		Transfer to additional paid-in-capital			(42,597	)
		Value at December 31, 2014			-
	Warrants issued Under PI SPA (Note L2c)
		Fair value at January 1, 2014			206,707
		Gain on derivative			(163,480	)
		Value at December 31, 2014			43,227
	Balance, December 31, 2014			$	43,227

Note_D_Concentration_of_Risk

Note D - Concentration of Risk	12 Months Ended
	Dec. 31, 2014
Risks and Uncertainties [Abstract]
Concentration Risk Disclosure [Text Block]	NOTE D—CONCENTRATION OF RISK
	Financial instruments which potentially subject the Company to risk primarily consist of cash and accounts receivables.
	The Company maintains its cash and cash equivalents with various financial institutions, which, at times may exceed the amounts insured by the Federal Deposit Insurance Corporation. The exposure to the Company is solely dependent upon daily bank balances and the respective strength of the financial institutions. The Company has not incurred any losses on these accounts. At December 31, 2014 and 2013, amounts in excess of insured limits were approximately $586,000 and $1,535,000, respectively.
	The Company extends credit to customers on an unsecured basis in the normal course of business. The Company’s policy is to perform an analysis of the recoverability of its receivables at the end of each reporting period and to establish allowances where appropriate. The Company analyzes historical bad debts and contract losses, customer concentrations, and customer credit-worthiness when evaluating the adequacy of the allowances.
	The Company had certain customers whose revenue individually represented 10% or more of the Company’s total revenue, as follows:
		Years Ended December 31,
		2014			2013
	Customer A		44	%		*
	Customer B		11	%		*
	Customer C		10	%		*
	Customer D		*			19	%
	Customer E		*			15	%
	*      Less than 10% of total revenue
	The Company had certain customers whose accounts receivable balances individually represented 10% or more of the Company’s total accounts receivable, as follows:
		As of December 31,
		2014			2013
	Customer A		62	%		*
	Customer F		*			50	%
	*      Less than 10% of total accounts receivable

Note_E_Equipment_and_Leashold_

Note E - Equipment and Leashold Improvements	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	NOTE E—EQUIPMENT AND LEASEHOLD IMPROVEMENTS
	Equipment and leasehold improvements consisted of the following as of December 31:
		2014			2013
	Equipment	$	395,546		$	378,074
	Furniture and fixtures		139,779			138,618
	Software		28,624			28,624
	Leasehold improvements		53,948			53,948
			617,897			599,264
	Less accumulated depreciation and amortization		(514,388	)		(474,202	)
	Total	$	103,509		$	125,062
	Depreciation and amortization were $40,186 and $28,618 for 2014 and 2013, respectively.

Note_F_Intangible_Assets

Note F - Intangible Assets	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block [Abstract]
Intangible Assets Disclosure [Text Block]	NOTE F—INTANGIBLE ASSETS
	Intangible assets consisted of the following as of December 31:
		2014							2013
		Gross		Accumulated			Net Carrying		Gross		Accumulated			Net Carrying
		Carrying		Amortization			Amount		Carrying		Amortization			Amount
		Amount							Amount
	Patents and patents pending	$	287,248	$	(125,904	)	$	161,344	$	287,248	$	(112,298	)	$	174,950
	Total	$	287,248	$	(125,904	)	$	161,344	$	287,248	$	(112,298	)	$	174,950
	Aggregate amortization expense for 2014 and 2013 was $13,606 and $20,961 respectively. The estimated aggregate amortization expense of intangible assets for the years following December 31, 2014 is approximately $14,000 per year for 2015 through 2019, and approximately $91,000 thereafter.

Note_G_Accrued_Laibilites

Note G - Accrued Laibilites	12 Months Ended
	Dec. 31, 2014
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	NOTE G—ACCRUED LIABILITIES
	Accrued liabilities consisted of the following as of December 31:
		2014		2013
	Compensation	$	203,349	$	11,102
	Compensated absences		116,439		112,609
	Dividends payable		3,435		3,435
	Accrued legal and accounting fees		92,000		84,609
	Sales tax payable		55,436		54,382
	Other		17,958		72,184
	Total	$	488,617	$	338,321

Note_H_Related_Party

Note H - Related Party	12 Months Ended
	Dec. 31, 2014
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	NOTE H—RELATED PARTY
	Consulting Arrangement with Thomas J. Colatosti (“Colatosti”)
	In connection with his appointment to the Board of Directors in September 2002, and as acting Chief Financial Officer from November 2008 to December 2009, the Company had entered into a number of consulting arrangements with Thomas Colatosti. Under the most recent arrangement, which was entered into on January 12, 2010, Mr. Colatosti provided services to the Company and its subsidiaries and affiliates for the two-year term ended December 31, 2011 at a rate of $5,000 per month. At December 31, 2013, Mr. Colatosti was owed $50,000, which was included in accounts payable. The amount was fully paid during 2014.

Note_I_Deferred_Revenue

Note I - Deferred Revenue	12 Months Ended
	Dec. 31, 2014
Deferred Revenue Disclosure [Abstract]
Deferred Revenue Disclosure [Text Block]	NOTE I—DEFERRED REVENUE
	Deferred revenue represents unearned revenue on maintenance contracts. Maintenance contracts include provisions for unspecified when-and-if available product updates and customer telephone support services, and are recognized ratably over the term of the service period. At December 31, 2014 and 2013, amounts in deferred revenue were approximately $429,000 and $528,000, respectively.

Note_J_Segment_Information

Note J - Segment Information	12 Months Ended
	Dec. 31, 2014
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	NOTE J—SEGMENT INFORMATION
	The Company has determined that its continuing operations are one discrete segment consisting of Biometric products. Geographically, North American sales accounted for approximately 91% and 97% of the Company’s total revenues for 2014 and 2013, respectively.

Note_K_Commitments_and_Conting

Note K - Commitments and Contingencies	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block Supplement [Abstract]
Commitments Disclosure [Text Block]	NOTE K—COMMITMENTS AND CONTINGENCIES
	Operating Leases
	The Company does not own any real estate but conducts operations from three leased premises. These non-cancelable operating leases expire at various dates through 2018. In addition to base rent, the Company pays for property taxes, maintenance, insurance and other occupancy expenses according to the terms of the individual leases.
	Future minimum rental commitments of non-cancelable operating leases are approximately as follows:
	Years ending December 31,
	2015	$	144,249
	2016		147,732
	2017		152,364
	2018		103,829
		$	548,174
	Rental expense was approximately $174,000 and $159,000 during 2014 and 2013, respectively.
	Lawsuit
	On or about March 13, 2014, LifeSouth Community Blood Centers, Inc. filed a lawsuit against us the Company in the Superior Court of Monmouth County, New Jersey (MON-L-1042-14) alleging a breach of a license agreement and seeking return of all amounts paid under the license in the amount of $718,500. We have denied all claims and asserted a counterclaim against LifeSouth for non-payment of support and maintenance service fees. Discovery has commenced and is proceeding. We have filed a motion seeking summary judgment in our favor with respect to all claims.

Note_L_Equity

Note L - Equity	12 Months Ended
	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	NOTE L— EQUITY
	1. Redeemable Preferred Stock
	Within the limits and restrictions provided in the Company’s Certificate of Incorporation, the Board of Directors has the authority, without further action by the shareholders, to issue up to 5,000,000 shares of preferred stock, $.0001 par value per share, in one or more series, and to fix, as to any such series, any dividend rate, redemption price, preference on liquidation or dissolution, sinking fund terms, conversion rights, voting rights, and any other preference or special rights and qualifications.
	2. Common Stock
	Effective February 3, 2015, the Company implemented a reverse stock split of its outstanding common stock at a ratio of 1 - for - 2.   The number of authorized shares and the par value of the Company's common stock and preferred stock were not affected by the reverse stock split. Stockholders who otherwise would be entitled to receive fractional shares were rounded up to the nearest whole share. The reverse stock split became effective on the OTCQB at the opening of trading on February 6, 2015.
	Holders of common stock have equal rights to receive dividends when, as and if declared by the Board of Directors, out of funds legally available therefor. Holders of common stock have one vote for each share held of record and do not have cumulative voting rights.
	Holders of common stock are entitled, upon liquidation of the Company, to share ratably in the net assets available for distribution, subject to the rights, if any, of holders of any preferred stock then outstanding. Shares of common stock are not redeemable and have no preemptive or similar rights. All outstanding shares of common stock are fully paid and nonassessable.
	Issuances of Common Stock
	a)     Securities Purchase Agreements dated February 26, 2013
	Pursuant to a Securities Purchase Agreement dated February 26, 2013 by and between the Company and DRNC (the “InterDigital SPA”), the Company issued to DRNC 2,013,468 post-split shares of its common stock at a purchase price $0.20 per post-split share, for an aggregate purchase price of $402,693. DRNC had anti-dilution rights under the InterDigital SPA that required the Company to issue additional shares to DRNC on a full-ratchet basis if the Company, within the nine months following February 26, 2013, sold or issued any common stock or common stock equivalents (other than sales or issuances to directors, officers, employees or independent contractors in the ordinary course of business for compensation purposes and stock splits and stock dividends payable in respect of the Company’s common stock) having a purchase, exercise or conversion price per post-split share of less than $0.20.  No shares were issued under the anti-dilution rights due to subsequent issuances.
	Concurrently with the closing of the transaction described above, the Company closed an equity financing with a number of private investors pursuant to a Securities Purchase Agreement (the “Private Investor SPA”). Pursuant to the Private Investor SPA, the Company issued to such investors 2,500,000 post-split shares of its common stock at a purchase price $0.20 per post-split share, for an aggregate purchase price of $500,000.
	In connection with the share issuances described above, the Company incurred costs of $46,176, which were offset against additional paid-in capital.
	The shares of common stock were subject to registration clauses.  The Company filed a registration statement on November 22, 2013 and such registration was declared effective on December 31, 2013.  See Note L2d.
	b)     Securities Purchase Agreement dated July 23, 2013
	Pursuant to a Securities Purchase Agreement, dated July 23, 2013, by and between the Company and a number of private and institutional investors (the “July Private Investor SPA”), the Company issued units to such investors consisting of 1,750,003 post-split shares of common stock and 1,750,003 warrants to purchase additional shares of common stock, at a purchase price of $0.60 per unit for an aggregate purchase price of $1,050,000. The Investors have anti-dilution rights under the July Private Investors SPA that require the Company to issue additional shares to Investors on an average-weighted basis if the Company, within the six months following July 23, 2013, sells or issues any common stock or common stock equivalents (other than sales or issuances to directors, officers, employees or independent contractors in the ordinary course of business for compensation purposes and stock splits and stock dividends payable in respect of the Company’s common stock) having a purchase, exercise or conversion price per share of less than $0.60 (see Note L2c below where the anti-dilution rights were triggered). The warrants were immediately exercisable at an exercise price of $0.80 per post-split share and have a term of five years. Effective November 22, 2013, the Company agreed to reduce the exercise price of the warrants to $0.50 per post-split share.
	In connection with the share issuances described above, the Company incurred costs of $135,594, including filing costs for the associated Registration Statement filed with the SEC pursuant to the registration rights clause in the July 2013 Private Investors SPA, which were offset against additional paid-in capital.
	The shares of common stock and the shares of common stock underlying the warrants were subject to a registration clause.  The Company filed a registration statement on November 22, 2013 and such registration was declared effective on December 31, 2013.  See Note L2d.
	Based on an evaluation as discussed in FASB ASC 815-15, “Embedded Derivatives” and FASB ASC 815-40-15, “Contracts in Entity’s Own Equity - Scope and Scope Exceptions,” the Company determined that the anti-dilution feature in the common stock issued was not considered indexed to its own stock because neither the occurrence of a sale of equity securities by the issuer at market nor the issuance of another equity contract with a lower strike price is an input to the fair value of a fixed-for-fixed option or forward on equity shares.  As such, the anti-dilution feature should be bifurcated from the common stock and accounted for as a derivative liability.
	The Company initially recorded derivative liabilities equal to their estimated fair value of $20,323. Such amount was also recorded as a reduction of additional paid-in capital. As discussed in Item c) below, the down round feature was triggered. As such, the Company marked-to-market the derivative liabilities at the dates of issuances. In addition, the Company was required to mark-to-market the derivative liabilities at December 31, 2013. For the year ended December 31, 2013, the Company recorded a loss on the change in fair value of the anti-dilution rights of $93,639. The Company did not value the derivative liability at December 31, 2013.  At such date, the Company determined that it was still highly unlikely that an equity financing would occur prior to January 23, 2014, the expiration date of the down round feature.  Such conclusion was based upon the discussion noted in Note L2c below.
	As discussed above, in November 2013, the Company agreed to reduce the exercise price of the warrants. Under GAAP, the warrants have to be revalued and a charge recorded if the value of the warrants under the new terms exceeds the value of the warrants under the old terms on the day before the change. No charge was recorded as the value of the “new” warrants was less than the value of the “old” warrants.
	c)     Securities Purchase Agreements dated October 25, 2013 and November 8, 2013
	Pursuant to a series of Private Investors Securities Purchase Agreements (the “PI SPA”), on October 25, 2013 and November 8, 2013, the Company issued to certain private investors an aggregate of 12,323,668 units consisting of 12,323,668 post-split shares of common stock (the “Shares”) and warrants to purchase an additional 12,323,668 post-split shares of our common stock (the “Warrants”) for an aggregate purchase price of $3,697,100. Each unit had a purchase price of $0.30 and consisted of one share of common stock and one Warrant. The Warrants are immediately exercisable at an exercise price of $0.50 per post-split share, have a term of three years, and are exercisable on a cashless basis if at any time following the nine month anniversary of the issuance date, there is not an effective registration statement covering the public resale of the shares of Common Stock underlying the Warrants.
	In connection with the share issuances described above, the Company incurred costs of $466,346, including filing costs for the associated Registration Statement filed with the SEC pursuant to the registration rights clause in the October and November 2013 Private Investors SPA, which were offset against additional paid-in capital.
	Investors in the PI SPA have certain anti-dilution rights which required the Company to issue additional shares of common stock to the investors if within the nine months following November 8, 2013, the Company, sells or issues any common stock or common stock equivalents (other than sales or issuances to directors, officers, employees or independent contractors in the ordinary course of business for compensation purposes and stock splits and stock dividends payable in respect of the Company’s common stock) having a purchase, exercise or conversion price per post-split share of less than $0.30.
	Based on an evaluation as discussed in FASB ASC 815-15, “Embedded Derivatives” and FASB ASC 815-40-15, “Contracts in Entity’s Own Equity - Scope and Scope Exceptions,” the Company determined that the anti-dilution features in the common stock issued were not considered indexed to its own stock because neither the occurrence of a sale of equity securities by the issuer at market nor the issuance of another equity contract with a lower strike price is an input to the fair value of a fixed-for-fixed option or forward on equity shares.  As such, the anti-dilution features should be bifurcated from the common stock and accounted for as a derivative liability.
	The Company did not value the derivative liability.  One of the key determinants of the Company’s decision to not value the derivative liability was the high likelihood that a future financing would not occur that would trigger the down round feature.  Whether a future equity financing would occur would be determined by the cash needs of the Company and management’s willingness to trigger the down round feature. The Company’s reasons were as follows:
	1.     The Company’s cash position after the completion of the PI SPA.
	2.     The stock price of the Company’s common stock.
	3.     The lack of enough available authorized shares to complete a large offering.
	Under GAAP, the Company is required to mark-to-market the derivative liability at the end of each reporting period. The Company did not value the derivative liability at December 31, 2013.  At such date, the Company determined that it was still highly unlikely that an equity financing would occur prior to July 8, 2014, the expiration date of the down round feature.  Such conclusion was based upon the discussion noted above.
	The Shares and shares of common stock underlying the Warrants were subject to a registration rights agreement.  The Company filed a registration statement on November 22, 2013 and such registration was declared effective on December 31, 2013.  See Note L2d. Under the November 2014 Securities Purchase Agreement, warrants to purchase 7,974,999 post-split shares of common stock previously issued in the November 2013 private placement were cancelled. See Note L2e.
	Pursuant to a placement agency letter agreement, the Company paid the placement agent cash commissions equal to 8% of the gross proceeds of the offering, reimbursed the placement agent for its reasonable out of pocket expenses, and issued to the placement agent warrants (the “Placement Agent Warrants”) to purchase an aggregate of 985,893 post-split shares of common stock. The Placement Agent Warrants have substantially the same terms as the Warrants issued to the investors, except the Placement Agent Warrants are immediately exercisable on a cashless basis.
	The cashless exercise features contained in the warrants are considered to be derivatives and the Company recorded warrant liabilities on the consolidated balance sheet. The Company initially recorded the warrant liabilities equal to their estimated fair value of $325,891. Such amount was also recorded as a reduction of additional paid-in capital. The Company is required to mark-to-market the warrant liabilities at the end of each reporting period. For the year ended December 31, 2014, the Company recorded a gain on the change in fair value of the cashless exercise features of $163,480, and as of December 31, 2014, the fair value of the cashless exercise features was $43,227. The fair value of the cashless exercise features was $206,707 as of December 31, 2013.
	The sales of securities in this offering triggered the anti-dilution rights set forth in the July Private Investor SPA. As a result, in connection with the October 25, 2013 closing, the per post-split share purchase price set forth in the July Private Investor SPA was reduced to $0.5444 resulting in the issuance of 178,726 additional post-split shares of common stock. In connection with the November 8, 2013 closing, the per post-split share purchase price set forth in the July Private Investor SPA was further reduced to $0.5368 resulting in the issuance of 27,307 additional post-split shares of common stock.
	d)     Registration Statement
	The Company filed a registration statement on Form S-1 with the SEC to register the public resale of the shares of common stock issued in the 2013 Securities Purchase Agreements described above. The registration statement was declared effective on December 31, 2013.
	e)     Securities Purchase Agreement dated November 13, 2014
	Pursuant to a Securities Purchase Agreement, dated November 13, 2014, by and between the Company and a number of private and institutional investors (the “November 2014 Private Investor SPA”), the Company issued to certain private investors 7,974,999 post-split shares of common stock and warrants to purchase an additional 11,962,501 post-split shares of common stock for aggregate gross proceeds of $1,595,000. In addition, for each share purchased in this offering, the investors surrendered to the Company for cancellation a warrant to acquire one share of our common stock which we previously issued in a private placement transaction in November 2013. This resulted in the cancellation of warrants to purchase an aggregate of 7,974,999 post-split shares of common stock. The public resale of these shares was included in an effective registration statement we previously filed with the Securities and Exchange Commission.
	The warrants have a term of five years and an exercise price of $0.30 per post-split share. Warrants to purchase 5,981,251 post-split shares of common stock were immediately exercisable. The remaining warrants to purchase 5,981,250 post-split shares of common stock became exercisable on the completion of a 1 - for - 2 reverse split of our common stock in February 2015.
	The warrants have customary anti-dilution protections including a “full ratchet” anti-dilution adjustment provision. In addition, if at any time between now and the two year anniversary of the effective date of the registration statement covering the public resale of such shares, the Company sells or issues shares of common stock or securities that are convertible into common stock at a price lower than $0.20 per share, the Company will be required to issue additional shares of common stock for no additional consideration.
	The warrants are exercisable on a cashless basis if at any time there is no effective registration statement covering the resale of the shares of common stock underlying the warrants.
	Based on an evaluation as discussed in FASB ASC 815-15, “Embedded Derivatives” and FASB ASC 815-40-15, “Contracts in Entity’s Own Equity - Scope and Scope Exceptions,” the Company determined that the anti-dilution feature in the common stock issued was not considered indexed to its own stock because neither the occurrence of a sale of equity securities by the issuer at market nor the issuance of another equity contract with a lower strike price is an input to the fair value of a fixed-for-fixed option or forward on equity shares.  As such, the anti-dilution features should be bifurcated from the common stock and accounted for as a derivative liability.
	The Company valued the anti-dilution feature using a Monte Carlo simulation at both the date of issuance and December 31, 2014 and determined that the anti-dilution feature had no value.
	The Company filed a registration statement on Form S-1 with the SEC to register the public resale of 13,956,250 of the shares of common stock issued in the 2014 Securities Purchase Agreement described above. The registration statement was declared effective on January 29, 2015.
	f)     Employees’ exercise options
	During the year ended December 31, 2014, 54,166 stock options were exercised resulting in the cashless issuance of 28,173 post-split shares of common stock. During the year ended December 31, 2013, 89,999 stock options were exercised resulting in the cashless issuance of 50,279 post-split shares of common stock.
	3. Warrants
	The Company has issued warrants to certain creditors, investors, investment bankers and consultants. A summary of warrant activity is as follows:
		Total Warrants			Weighted		Weighted		Aggregate
					average		average		intrinsic
					exercise		remaining		value
					price		life
							(in years)
	Outstanding, as of January1, 2013		4,125,000		$	0.6		2.97
	Granted		15,209,579			0.5
	Exercised		—			—
	Forfeited		—			—
	Expired		—			—
	Outstanding, as of December 31, 2013		19,334,579			0.52		2.79		—
	Granted		11,962,501			0.3
	Exercised		(150,000	)		0.2
	Forfeited		(7,974,999	)		0.5
	Expired		(125,000	)		0.6
	Repurchased		(4,000,000	)		0.6
Vested or expected to vest at December 31, 2014		19,047,081			0.37		3.91		—
Exercisable at December 31, 2014		13,065,816		$	0.41		3.47		—
On August 15, 2013, the Company issued a warrant to purchase 150,000 post-split shares of the Company’s common stock to an independent contractor. On March 11, 2014, the warrant was exercised on a cashless basis resulting in the issuance of 76,830 post-split shares of common stock.
The cashless exercise feature contained in the warrant was considered to be a derivative and the Company recorded a warrant liability on the condensed consolidated balance sheet. The Company recorded the warrant liability equal to its estimated fair value. The Company was required to mark-to-market the warrant liabilities at the end of each reporting period. As the warrant was exercised, the Company marked-to-market the warrant on the day before the exercise and such value was then transferred to additional paid-in capital. For the year ended December 31, 2014, the Company recorded a loss on the change in fair value of the cashless exercise feature of $6,227. $42,597, the value of the cashless exercise feature as of March 10, 2014, was transferred to additional paid-in capital. The fair value of the cashless exercise feature was $36,370 as of December 31, 2013.
On January 27, 2014, the Company repurchased a warrant for the purchase of 4,000,000 post-split shares of common stock from the Shaar Fund Ltd. at a purchase price of $150,000.   The warrant was exercisable at a strike price of $0.60 per post-split share through December 31, 2015.

Note_M_Stock_Options

Note M - Stock Options	12 Months Ended
	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	NOTE M—STOCK OPTIONS
	1999 Stock Option Plan
	During 1999, the Board of Directors of the Company adopted the 1999 Stock Option Plan (the 1999 Plan). The 1999 Plan was not presented to stockholders for approval and thus incentive stock options are not available under the plan. Under the 1999 Plan, 1,000,000 shares of common stock are reserved for issuance to employees, officers, directors, and consultants of the Company at exercise prices which may not be below 85% of fair market value. The term of nonstatutory stock options granted may not exceed ten years. Options issued under the Plan vest pursuant to the terms of stock option agreements with the recipients. In the event of a change in control, as defined, all options outstanding vest immediately. The 1999 Plan expired in August 2009.
	2004 Stock Option Plan
	On October 12, 2004, the Board of Directors of the Company approved the 2004 Stock Option Plan (the 2004 Plan). The 2004 Plan has not yet been presented to stockholders for approval and thus incentive stock options are not available under this plan. Under the terms of this plan, 2,000,000 post-split shares of common stock are reserved for issuance to employees, officers, directors, and consultants of the Company at exercise prices which may not be below 85% of fair market value. The term of stock options granted may not exceed ten years. Options issued under the Plan vest pursuant to the terms of stock option agreements with the recipients. In the event of a change in control, as defined, all options outstanding vest immediately. The Plan expired in October 2014.
	Non-Plan Stock Options
	Periodically, the Company has granted options outside of the 1999 and 2004 Plans to various employees and consultants. In the event of change in control, as defined, certain of the non-plan options outstanding vest immediately.
	Stock Option Activity
	Information summarizing option activity is as follows:
		Number of Options											Weighted			Weighted			Aggregate
													average			average			intrinsic
													exercise			remaining
																life
		1999 Plan		2004 Plan			Non Plan			Total			price			(in years)			value
	Outstanding, as of December 31, 2012		250,000		1,381,136			—			1,631,136		$	0.32
	Granted		—		575,000			600,000			1,175,000			0.34
	Exercised		—		(89,999	)		—			(89,999	)		0.26
	Forfeited		—		(20,833	)		—			(20,833	)		0.32
	Expired		—		—			—			—			—
	Outstanding, as of December 31, 2013		250,000		1,845,304			600,000			2,695,304		$	0.33			4.48		$	136,787
	Granted		—		—			1,835,000			1,835,000			0.39
	Exercised		—		(54,166	)		—			(54,166	)		0.25
	Forfeited		—		(129,168	)		(225,000	)		(354,168	)		0.34
	Expired		—		(26,665	)		—			(26,665	)		0.29
	Outstanding, as of December 31, 2014		250,000		1,635,305			2,210,000			4,095,305		$	0.36			4.45		$	24,325
	Vested or expected to vest at December 31, 2014										3,385,905		$	0.36			4.06		$	24,325
	Exercisable at December 31, 2014										1,726,963		$	0.33			2.17		$	24,325
	The options outstanding and exercisable at December 31, 2014 were in the following exercise price ranges:
					Options Outstanding									Options Exercisable
	Range of exercise prices				Number of			Weighted			Weighted			Number			Weighted
					shares			average			average			exercisable			average
								exercise			remaining						exercise
								price			life (in years)						price
	$0.14 - 0.42					3,890,305		$	0.33			4.58			1,521,963		$	0.26
	0.43 - 0.80					35,000			0.8			2.02			35,000			0.8
	0.81 - 0.95					170,000			0.92			2.02			170,000			0.92
	$0.14 - 0.95					4,095,305									1,726,963
	The aggregate intrinsic value in the table above represents the total intrinsic value, based on the Company’s closing stock price of $0.22 as of December 31, 2014, which would have been received by the option holders had all option holders exercised their options as of that date. The total number of in-the-money options exercisable as of December 31, 2014 was 550,000.
	The weighted average fair value of options granted during the years ended December 31, 2014 and 2013 was $0.32 and $0.30 per share, respectively. The total intrinsic value of options exercised during the years ended December 31, 2014 and 2013 was $14,650, and $31,643, respectively. The total fair value of shares vested during the years ended December 31, 2014 and 2013 was $143,382 and $42,058 respectively.
	As of December 31, 2014 future compensation cost related to nonvested stock options is $438,571 and will be recognized over an estimated weighted average period of 1.93 years.

Note_N_Income_Taxes

Note N - Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	NOTE N—INCOME TAXES
	There was no provision for federal or state taxes as at December 31, 2014 and 2013.
	The Company has deferred taxes due to income tax credits, net operating loss carryforwards, and the effect of temporary differences between the carrying values of certain assets and liabilities for financial reporting and income tax purposes. Significant components of deferred taxes are as follows at December 31:
		2014			2013
	Current asset:
	Accrued compensation	$	88,000		$	49,000
	Accounts receivable allowance		8,000			8,000
	Non-current asset (liability):
	Stock-based compensation		174,000			205,000
	Basis differences in fixed assets		(26,000	)		(19,000	)
	Basis differences in intangible assets		(63,000	)		(69,000	)
	Net operating loss and credit carryforwards		17,540,000			17,217,000
	Valuation allowances		(17,721,000	)		(17,391,000	)
		$	—		$	—
	The Company has a valuation allowance against the full amount of its net deferred taxes due to the uncertainty of realization of the deferred tax assets due to operating loss history of the Company. The Company currently provides a valuation allowance against deferred taxes when it is more likely than not that some portion, or all of its deferred tax assets will not be realized. The valuation allowance could be reduced or eliminated based on future earnings and future estimates of taxable income. Similarly, income tax benefits related to stock options exercised have not been recognized in the financial statements.
	As of December 31, 2014, the Company has federal net operating loss carryforwards of approximately $49,200,000 subject to expiration between 2019 and 2034.  These net operating loss carryforwards are subject to the limitations under Section 382 of the Internal Revenue Code due to changes in the equity ownership of the Company.
	A reconciliation of the effective income tax rate on operations reflected in the Statements of Operations to the US Federal statutory income tax rate is presented below.
		2014			2013
	Federal statutory income tax rate		34	%		34	%
	Permanent differences		—			(3	)
	Effect of net operating loss		(34	)		(31	)
	Effective tax rate		—	%		—	%
	The Company has not been audited by the Internal Revenue Service (“IRS”) or any states in connection with income taxes. The Company files income tax returns in the U.S. federal jurisdiction and various state jurisdictions. The periods from 2011 through 2014 remain open to examination by the IRS and state jurisdictions. The Company believes it is not subject to any tax audit risk beyond those periods. The Company’s policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. The Company does not have any accrued interest or penalties associated with any unrecognized tax benefits, nor was any significant interest expense recognized during the years ended December 31, 2014 and 2013.

Note_O_Profit_Sharing_Plan

Note O - Profit Sharing Plan	12 Months Ended
	Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Pension and Other Postretirement Benefits Disclosure [Text Block]	NOTE O—PROFIT SHARING PLAN
	The Company has established a savings plan under section 401(k) of the Internal Revenue Code. All employees of the Company, after completing one day of service are eligible to enroll in the 401(k) plan. Participating employees may elect to defer a portion of their salary on a pre-tax basis up to the limits as provided by the IRS Code. The Company is not required to match employee contributions but may do so at its discretion. The Company made no contributions during the years ended December 31, 2014 and 2013.

Note_P_Earnings_Per_Share_EPS

Note P - Earnings Per Share (EPS)	12 Months Ended
	Dec. 31, 2014
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	NOTE P—EARNINGS PER SHARE (EPS)
	The Company’s basic EPS is calculated using net income (loss) available to common shareholders and the weighted-average number of shares outstanding during the reporting period. Diluted EPS includes the effect from potential issuance of common stock, such as stock issuable pursuant to the exercise of stock options and warrants and the assumed conversion of convertible notes and preferred stock.
	The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive even though the exercise price was less than the average market price of the common shares.
		Years ended December 31,
		2014		2013
	Stock options		516,214		922,265
	Warrants		2,013,491		83,345
	Potentially dilutive securities		2,529,705		1,005,610
	Items excluded from the diluted per share calculation because the exercise price was greater than the average market price of the common shares:
		Years ended December 31,
		2014		2013
	Stock options		1,615,000		205,000
	Warrants		7,084,580		19,184,565
	Total		8,699,580		19,389,565

Note_Q_Subsequent_Events

Note Q - Subsequent Events	12 Months Ended
	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events [Text Block]	NOTE Q—SUBSEQUENT EVENTS
	The Company has reviewed subsequent events through the date of this filing.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)

12 Months Ended

Dec. 31, 2014

Accounting Policies [Abstract]

Basis of Accounting, Policy [Policy Text Block]

Basis of Presentation

The Company has incurred significant losses to date, and at December 31, 2014, it had an accumulated deficit of approximately $57 million. In addition, broad commercial acceptance of the Company’s technology is critical to the Company’s success and ability to generate future revenues. At December 31, 2014, our total cash and cash equivalents were approximately $844,000, as compared to approximately $2,023,000 at December 31, 2013.

As discussed below, the Company has financed itself in the past through access to the capital markets by issuing secured and convertible debt securities, convertible preferred stock, common stock, and recently through factoring receivables. The Company currently requires approximately $475,000 per month to conduct operations, a monthly amount that it has been unable to achieve through revenue generation.

If the Company is unable to generate sufficient revenue to meet our goals, it will need to obtain additional third-party financing to (i) conduct the sales, marketing and technical support necessary to execute its plan to substantially grow operations, increase revenue and serve a significant customer base; and (ii) provide working capital. No assurance can be given that any form of additional financing will be available on terms acceptable to the Company, that adequate financing will be obtained by the Company in order to meet its needs, or that such financing would not be dilutive to existing shareholders.

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America ("GAAP"), which contemplate continuation of the Company as a going concern, and assumes continuity of operations, realization of assets and the satisfaction of liabilities and commitments in the normal course of business. The matters described in the preceding paragraphs raise substantial doubt about the Company’s ability to continue as a going concern. Recoverability of a major portion of the recorded asset amounts shown in the accompanying balance sheet is dependent upon the Company’s ability to meet its financing requirements on a continuing basis, and become profitable in its future operations. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.

Effective February 3, 2015, the Company implemented a reverse stock split of its outstanding common stock at a ratio of 1 - for - 2 shares. All share figures and results are reflected on a post-split basis. See Note L.

Consolidation, Policy [Policy Text Block]

Basis of Consolidation

The accompanying consolidated financial statements include the accounts of BIO-key International, Inc. and its wholly-owned subsidiary (collectively, the “Company”). Intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates, Policy [Policy Text Block]

Use of Estimates

Our consolidated financial statements are prepared in accordance with GAAP as set forth in the Financial Accounting Standards Board’s (FASB) Accounting Standards Codification (ASC) and consider the various staff accounting bulletins and other applicable guidance issued by the U.S. Securities and Exchange Commission (SEC). These accounting principles require us to make certain estimates, judgments and assumptions. The Company believes that the estimates, judgments and assumptions upon which it relies are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. To the extent there are material differences between these estimates, judgments or assumptions and actual results, its consolidated financial statements will be affected. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does not require management’s judgment in its application. There are also areas in which management’s judgment in selecting among available alternatives would not produce a materially different result.

Revenue Recognition, Policy [Policy Text Block]

Revenue Recognition

Revenues from software licensing are recognized in accordance with ASC 985-605, "Software Revenue Recognition." Accordingly, revenue from software licensing is recognized when all of the following criteria are met: persuasive evidence of an arrangement exists, delivery has occurred, the fee is fixed or determinable, and collectability is probable.

The Company intends to enter into arrangements with end users for items which may include software license fees, and services or various combinations thereof. For each arrangement, revenues will be recognized when evidence of an agreement has been documented, the fees are fixed or determinable, collection of fees is probable, delivery of the product has occurred and no other significant obligations remain.

Multiple-Element Arrangements: For multiple-element arrangements, the Company applies the residual method in accordance with ASC 985-605. The residual method requires that the portion of the total arrangement fee attributable to the undelivered elements be deferred based on its vendor-specific objective evidence ("VSOE") of fair value and subsequently recognized as the service is delivered. The difference between the total arrangement fee and the amount deferred for the undelivered elements is recognized as revenue related to the delivered elements, which is generally the software license. VSOE of fair value for all elements in an arrangement is based upon the normal pricing for those products and services when sold separately. VSOE of fair value for support services is additionally determined by the renewal rate in customer contracts. The Company has established VSOE of fair value for support as well as consulting services.

License Revenues: Amounts allocated to license revenues are recognized at the time of delivery of the software and all other revenue recognition criteria discussed above have been met.

Revenue from licensing software, which requires significant customization and modification, is recognized using the percentage of completion method, based on the hours of effort incurred by the Company in relation to the total estimated hours to complete. In instances where third party hardware, software or services form a significant portion of a customer’s contract, the Company recognizes revenue for the element of software customization by the percentage of completion method described above. Otherwise, third party hardware, software, and services are recognized upon shipment or acceptance as appropriate. If the Company makes different judgments or utilizes different estimates of the total amount of work expected to be required to customize or modify the software, the timing and revenue recognition, from period to period, and the margins on the project in the reporting period, may differ materially from amounts reported. Anticipated contract losses are recognized as soon as they become known and are estimable.

Service Revenues: Revenues from services are comprised of maintenance and consulting and implementation services. Maintenance revenues include providing for unspecified when-and-if available product updates and customer telephone support services, and are recognized ratably over the term of the service period. Consulting services are generally sold on a time-and-materials basis and include a range of services including installation of software and assisting in the design of interfaces to allow the software to operate in customized environments. Services are generally separable from other elements under the arrangement since performance of the services are not essential to the functionality of any other element of the transaction and are described in the contract such that the total price of the arrangement would be expected to vary as the result of the inclusion or exclusion of the services. Revenues from services are generally recognized as the services are performed.

The Company provides customers, free of charge or at a minimal cost, testing kits which potential licensing customers may use to test compatibility/acceptance of the Company’s technology with the customer’s intended applications.

Costs and other expenses: Includes professional compensation and other direct contract expenses, as well as costs attributable to the support of client service professional staff, depreciation and amortization costs related to assets used in revenue-generating activities, and other costs attributable to serving the Company’s client base. Professional compensation consists of payroll costs and related benefits including stock-based compensation and bonuses. Other direct contract expenses include costs directly attributable to client engagements, such as out-of-pocket costs including travel and subsistence for client service professional staff, costs of hardware and software and costs of subcontractors. The allocation of lease and facilities charges for occupied offices is included in costs of service.

The Company accounts for its warranties under the FASB ASC 450, “Contingencies.” The Company generally warrants that its products are free from defects in material and workmanship for a period of one year from the date of initial receipt by its customers. The warranty does not cover any losses or damage that occurs as a result of improper installation, misuse or neglect or repair or modification by anyone other than the Company or its authorized repair agent. The Company’s policy is to accrue anticipated warranty costs based upon historical percentages of items returned for repair within one year of the initial sale. The Company’s repair rate of products under warranty has been minimal, and a historical percentage has not been established. The Company’s software license agreements generally include certain provisions for indemnifying customers against liabilities if the Company’s software products infringe upon a third party’s intellectual property rights. The Company has not provided for any reserves for warranty liabilities as it was determined to be immaterial.

Cash and Cash Equivalents, Policy [Policy Text Block]

Cash Equivalents

Cash equivalents consist of liquid investments with original maturities of three months or less.  At December 31, 2014 and 2013, cash equivalents consisted of a money market account.

Receivables, Policy [Policy Text Block]

Accounts Receivable

Accounts receivable are carried at original amount less an estimate made for doubtful receivables based on a review of all outstanding amounts on a monthly basis. Management determines the allowance for doubtful receivables by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history, and current economic conditions. Accounts receivable are written off when deemed uncollectible. Recoveries of accounts receivable previously written off are recorded when received. Accounts receivable at December 31, 2014 and 2013 consisted of the following:

December 31,

2014

2013

Accounts receivable

$

645,867

$

304,551

Allowance for doubtful accounts

(20,526

)

(20,526

)

Accounts receivable, net allowances for doubtful accounts

$

625,341

$

284,025

The allowance for doubtful accounts for the years ended December 31, 2014 and 2013 is as follows:

Balance at

Charged to Costs

Deductions From

Balance at

Beginning of Year

and Expenses

Reserves

End of Year

Year Ended December 31, 2014

Allowance for Doubtful Accounts

$

20,526

$

-

$

-

$

20,526

Year Ended December 31, 2013

Allowance for Doubtful Accounts

$

20,526

$

-

$

-

$

20,526

Property, Plant and Equipment, Policy [Policy Text Block]

Equipment and Leasehold Improvements, Intangible Assets and Depreciation and Amortization

Equipment and leasehold improvements are stated at cost.  Depreciation is provided for in amounts sufficient to relate the cost of depreciable assets to operations over the estimated service lives, principally using straight-line methods. Leasehold improvements are amortized over the shorter of the life of the improvement or the lease term, using the straight-line method.

The estimated useful lives used to compute depreciation and amortization for financial reporting purposes are as follows:

2014

Equipment and leasehold improvements

Equipment (years)

3

-

5

Furniture and fixtures (years)

3

-

5

Software (years)

3

Leasehold improvements

life or lease term

Intangible assets consist of patents.  Patent costs are capitalized until patents are awarded. Upon award, such costs are amortized using the straight-line method over their respective economic lives. If a patent is denied, all costs are charged to operations in that year.

Goodwill and Intangible Assets, Policy [Policy Text Block]

Impairment or Disposal of Long Lived Assets, including Intangible Assets

The Company reviews long-lived assets, including intangible assets subject to amortization, whenever events or changes in circumstances indicate that the carrying amount of such an asset may not be recoverable. Recoverability of these assets is measured by comparison of their carrying amount to the future undiscounted cash flows the assets are expected to generate. If such assets are considered impaired, the impairment to be recognized is equal to the amount by which the carrying value of the assets exceeds their fair value determined by either a quoted market price, if any, or a value determined by utilizing a discounted cash flow technique. In assessing recoverability, the Company must make assumptions regarding estimated future cash flows and discount factors. If these estimates or related assumptions change in the future, the Company may be required to record impairment charges. Intangible assets with determinable lives are amortized over their estimated useful lives, based upon the pattern in which the expected benefits will be realized, or on a straight-line basis, whichever is greater. We did not record any impairment charges in any of the years presented.

Advertising Costs, Policy [Policy Text Block]

Advertising Expense

The Company expenses the costs of advertising as incurred. Advertising expenses for 2014 and 2013 were approximately $252,000 and $178,000, respectively.

Revenue Recognition, Deferred Revenue [Policy Text Block]

Deferred Revenue

Deferred revenue includes customer advances and amounts that have been billed per the contractual terms but have not been recognized as revenue. The majority of these amounts are related to maintenance contracts for which the revenue is recognized ratably over the applicable term, which generally is 12 months from the date the customer is delivered the products.

Research and Development Expense, Policy [Policy Text Block]

Research and Development Expenditures

Research and development expenses include costs directly attributable to the conduct of research and development programs primarily related to the development of our software products and improving the efficiency and capabilities of our existing software. Such costs include salaries, payroll taxes, employee benefit costs, materials, supplies, depreciation on research equipment, services provided by outside contractors, and the allocable portions of facility costs, such as rent, utilities, insurance, repairs and maintenance, depreciation and general support services. All costs associated with research and development are expensed as incurred.

Earnings Per Share, Policy [Policy Text Block]

Earnings Per Share of Common Stock (“EPS”)

The Company’s EPS is calculated by dividing net income (loss) applicable to common stockholders by the weighted-average number of common shares outstanding during the reporting period. Diluted EPS includes the effect from potential issuances of common stock, such as stock issuable pursuant to the exercise of stock options and warrants, when the effect of their inclusion is dilutive. See Note P - Earnings Per Share “EPS” for additional information.

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

Accounting for Stock-Based Compensation

The Company accounts for share based compensation in accordance with the provisions of ASC 718-10, “Compensation — Stock Compensation,” which requires measurement of compensation cost for all stock awards at fair value on date of grant and recognition of compensation over the service period for awards expected to vest. The majority of its share-based compensation arrangements vest over either a three or four year vesting schedule. The Company expenses its share-based compensation under the ratable method, which treats each vesting tranche as if it were an individual grant. The fair value of stock options is determined using the Black-Scholes valuation model, and requires the input of highly subjective assumptions. These assumptions include estimating the length of time employees will retain their vested stock options before exercising them (the “expected option term”), the estimated volatility of its common stock price over the option’s expected term, the risk-free interest rate over the option’s expected term, and the Company’s expected annual dividend yield. Changes in these subjective assumptions can materially affect the estimate of fair value of stock-based compensation and consequently, the related amount recognized as an expense in the consolidated statements of operations. As required under the accounting rules, the Company reviews its valuation assumptions at each grant date and, as a result, the Company is likely to change its valuation assumptions used to value employee stock-based awards granted in future periods. The values derived from using the Black-Scholes model are recognized as expense over the service period, net of estimated forfeitures (the number of individuals that will ultimately not complete their vesting requirements). The estimation of stock awards that will ultimately vest requires significant judgment. The Company considers many factors when estimating expected forfeitures, including types of awards, employee class, and historical experience. Actual results, and future changes in estimates, may differ substantially from current estimates.

The compensation expense recognized under ASC 718 amounted to $207,258 and $81,642 for 2014 and 2013 respectively.

The following table presents share-based compensation expenses included in the Company’s consolidated statements of operations:

Year ended

December 31,

2014

2013

Selling, general and administrative

$

161,466

$

60,151

Research, development and engineering

45,792

21,491

$

207,258

$

81,642

Valuation Assumptions for Stock Options

For 2014 and 2013, 1,835,000 and 1,175,000 stock options were granted, respectively. The fair value of each option was estimated on the date of grant using the Black-Scholes option-pricing model with the following assumptions:

Year ended

December 31,

2014

2013

Risk free interest rate

1.34

%

0.68

%

Expected life of options (in years)

4.5

4.5

Expected dividends

0

%

0

%

Volatility of stock price

119

%

139

%

The stock volatility for each grant is determined based on the review of the experience of the weighted average of historical daily price changes of the Company’s common stock over the expected option term. The expected term was determined using the simplified method for estimating expected option life, which qualify as “plain-vanilla” options; and the risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods corresponding with the expected life of the option.

Derivatives, Embedded Derivatives [Policy Text Block]

Derivative Liabilities

In connection with the issuances of equity instruments or debt, the Company may issue options or warrants to purchase common stock. In certain circumstances, these options or warrants may be classified as liabilities, rather than as equity. In addition, the equity instrument or debt may contain embedded derivative instruments, such as conversion options or listing requirements, which in certain circumstances may be required to be bifurcated from the associated host instrument and accounted for separately as a derivative liability instrument. The Company accounts for derivative liability instruments under the provisions of FASB ASC 815, “Derivatives and Hedging.”

Deferred Charges, Policy [Policy Text Block]

Deferred Costs

Costs incurred with obtaining and executing debt arrangements are capitalized and amortized to interest expense using the effective interest method over the term of the related debt.

Income Tax, Policy [Policy Text Block]

Income Taxes

The provision for, or benefit from, income taxes includes deferred taxes resulting from the temporary differences in income for financial and tax purposes using the liability method. Such temporary differences result primarily from the differences in the carrying value of assets and liabilities. Future realization of deferred income tax assets requires sufficient taxable income within the carryback, carryforward period available under tax law. The Company evaluates, on a quarterly basis whether, based on all available evidence, if it is probable that the deferred income tax assets are realizable. Valuation allowances are established when it is more likely than not that the tax benefit of the deferred tax asset will not be realized. The evaluation, as prescribed by ASC 740-10, “Income Taxes,” includes the consideration of all available evidence, both positive and negative, regarding historical operating results including recent years with reported losses, the estimated timing of future reversals of existing taxable temporary differences, estimated future taxable income exclusive of reversing temporary differences and carryforwards, and potential tax planning strategies which may be employed to prevent an operating loss or tax credit carryforward from expiring unused. Because of the Company’s historical performance and estimated future taxable income, a full valuation allowance has been established.

The Company accounts for uncertain tax provisions in accordance with ASC 740-10-05, “Accounting for Uncertainty in Income Taxes.” The ASC clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements. The ASC prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The ASC provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.

New Accounting Pronouncements, Policy [Policy Text Block]

Recent Accounting Pronouncements

Effective January 1, 2014, the Company adopted Accounting Standards Update (“ASU”) No. 2013-11, “Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists” (“ASU 2013-11”). ASU 2013-11 is expected to reduce diversity in practice by providing guidance on the presentation of unrecognized tax benefits and will better reflect the manner in which an entity would settle at the reporting date any additional income taxes that would result from the disallowance of a tax position when net operating loss carryforwards, similar tax losses, or tax credit carryforwards exist. The amendments in this update should be applied prospectively for annual and interim periods beginning after December 15, 2013. The adoption of ASU 2013-11 did not have a material effect on its consolidated financial statements.

In May 2014, ASU No. 2014-09, “Revenue from Contracts with Customers” was issued. The comprehensive new standard will supersede existing revenue recognition guidance and require revenue to be recognized when promised goods or services are transferred to customers in amounts that reflect the consideration to which the Company expects to be entitled in exchange for those goods or services. The guidance will also require that certain contract costs incurred to obtain or fulfill a contract, such as sales commissions, be capitalized as an asset and amortized as revenue is recognized. Adoption of the new rules could affect the timing of both revenue recognition and the incurrence of contract costs for certain transactions. The guidance permits two implementation approaches, one requiring retrospective application of the new standard with restatement of prior years and one requiring prospective application of the new standard with disclosure of results under old standards. The new standard is effective for reporting periods beginning after December 15, 2016 and early adoption is not permitted. For us, the new standard will be effective January 1, 2017. The Company is currently evaluating the impact of adoption and the implementation approach to be used.

In June 2014, ASU 2014-12, “Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period” (“ASU No. 2014-12”) was issued.  ASU No. 2014-12 requires that a performance target that affects vesting and that could be achieved after the requisite service period is treated as a performance condition. An entity should recognize compensation cost in the period in which it becomes probable that the performance target will be achieved and should represent the compensation cost attributable to the periods for which the requisite service has already been rendered. If the performance target becomes probable of being achieved before the end of the requisite service period, the remaining unrecognized compensation cost should be recognized prospectively over the remaining requisite service period. The total amount of compensation cost recognized during and after the requisite service period should reflect the number of awards that are expected to vest and should be adjusted to reflect those awards that ultimately vest. ASU 2014-12 becomes effective for interim and annual periods beginning on or after December 15, 2015. Early adoption is permitted.  The Company is currently evaluating the effects of adopting ASU 2014-12 on its consolidated financial statements but the adoption is not expected to have a significant impact.

In June 2014, ASU 2014-15, “Presentation of Financial Statements – Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern” (“ASU No. 2014-15”) was issued.  Before the issuance of ASU 2014-15, there was no guidance in U.S. GAAP about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern or to provide related footnote disclosures. This guidance is expected to reduce the diversity in the timing and content of footnote disclosures. ASU 2014-15 requires management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards as specified in the guidance. ASU 2014-15 becomes effective for the annual period ending after December 15, 2016 and for annual and interim periods thereafter. Early adoption is permitted. The Company is currently evaluating the effects of adopting ASU 2014-15 on its consolidated financial statements but the adoption is not expected to have a significant impact.

In January 2015, ASU No. 2015-01, “Income Statement – Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary items” (“ASU 2015-01”) was issued. ASU 2015-01 eliminates from GAAP the concept of extraordinary items. ASU 2015-01 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2015. A reporting entity may apply the amendments prospectively. A reporting entity also may apply the amendments retrospectively to all prior periods presented in the financial statements. Early adoption is permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. The Company is currently evaluating the effects of adopting ASU 2014-15 on its consolidated financial statements but the adoption is not expected to have a significant impact.

Management does not believe that any other recently issued, but not yet effective, accounting standard if currently adopted would have a material effect on the accompanying consolidated financial statements.

Note_A_The_Company_and_Summary1

Note A - The Company and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block [Abstract]
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]			December 31,
			2014			2013
	Accounts receivable		$	645,867		$	304,551
	Allowance for doubtful accounts			(20,526	)		(20,526	)
	Accounts receivable, net allowances for doubtful accounts		$	625,341		$	284,025
Summary of Valuation Allowance [Table Text Block]			Balance at			Charged to Costs			Deductions From		Balance at
			Beginning of Year			and Expenses			Reserves		End of Year
	Year Ended December 31, 2014
	Allowance for Doubtful Accounts		$	20,526		$	-		$	-	$	20,526
	Year Ended December 31, 2013
	Allowance for Doubtful Accounts		$	20,526		$	-		$	-	$	20,526
Useful Lives of Property, Plan and Equipment [Table Text Block]		2014
	Equipment and leasehold improvements
	Equipment (years)	3	-	5
	Furniture and fixtures (years)	3	-	5
	Software (years)		3
	Leasehold improvements		life or lease term
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]			Year ended
			December 31,
			2014			2013
	Selling, general and administrative		$	161,466		$	60,151
	Research, development and engineering			45,792			21,491
			$	207,258		$	81,642
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]			Year ended
			December 31,
			2014			2013
	Risk free interest rate			1.34	%		0.68	%
	Expected life of options (in years)			4.5			4.5
	Expected dividends			0	%		0	%
	Volatility of stock price			119	%		139	%

Note_B_Factoring_Tables

Note B - Factoring (Tables)	12 Months Ended
	Dec. 31, 2014
Note B - Factoring (Tables) [Line Items]
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]		December 31,
		2014			2013
	Accounts receivable	$	645,867		$	304,551
	Allowance for doubtful accounts		(20,526	)		(20,526	)
	Accounts receivable, net allowances for doubtful accounts	$	625,341		$	284,025
Factored Accounts Receivable [Member]
Note B - Factoring (Tables) [Line Items]
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]		Original Invoice			Factored			Factored
		Value			Amount			Balance due
	Year Ended December 31, 2014
	Factored accounts receivable	$	306,625		$	229,968		$	76,657
	Year Ended December 31, 2013
	Factored accounts receivable	$	9,795		$	7,346		$	2,449

Note_C_Fair_Values_of_Financia1

Note C - Fair Values of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2014
Fair Value Disclosures [Abstract]
Fair Value Inputs, Assets, Quantitative Information [Table Text Block]		2014
	Risk free interest rate	0.59%	-	0.61%
	Expected term	1.82	-	1.86
	Expected dividends		0
	Volatility of stock price	79.30%	-	79.70%
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]	Compensatory Warrant (Note L3)
		Fair value at January 1, 2014			36,370
		Loss on derivative			6,227
		Transfer to additional paid-in-capital			(42,597	)
		Value at December 31, 2014			-
	Warrants issued Under PI SPA (Note L2c)
		Fair value at January 1, 2014			206,707
		Gain on derivative			(163,480	)
		Value at December 31, 2014			43,227
	Balance, December 31, 2014			$	43,227

Note_D_Concentration_of_Risk_T

Note D - Concentration of Risk (Tables)	12 Months Ended
	Dec. 31, 2014
Risks and Uncertainties [Abstract]
Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]		Years Ended December 31,
		2014			2013
	Customer A		44	%		*
	Customer B		11	%		*
	Customer C		10	%		*
	Customer D		*			19	%
	Customer E		*			15	%
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]		As of December 31,
		2014			2013
	Customer A		62	%		*
	Customer F		*			50	%

Note_E_Equipment_and_Leashold_1

Note E - Equipment and Leashold Improvements (Tables)	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]		2014			2013
	Equipment	$	395,546		$	378,074
	Furniture and fixtures		139,779			138,618
	Software		28,624			28,624
	Leasehold improvements		53,948			53,948
			617,897			599,264
	Less accumulated depreciation and amortization		(514,388	)		(474,202	)
	Total	$	103,509		$	125,062

Note_F_Intangible_Assets_Table

Note F - Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block [Abstract]
Schedule of Finite-Lived Intangible Assets [Table Text Block]		2014							2013
		Gross		Accumulated			Net Carrying		Gross		Accumulated			Net Carrying
		Carrying		Amortization			Amount		Carrying		Amortization			Amount
		Amount							Amount
	Patents and patents pending	$	287,248	$	(125,904	)	$	161,344	$	287,248	$	(112,298	)	$	174,950
	Total	$	287,248	$	(125,904	)	$	161,344	$	287,248	$	(112,298	)	$	174,950

Note_G_Accrued_Laibilites_Tabl

Note G - Accrued Laibilites (Tables)	12 Months Ended
	Dec. 31, 2014
Payables and Accruals [Abstract]
Schedule of Accrued Liabilities [Table Text Block]		2014		2013
	Compensation	$	203,349	$	11,102
	Compensated absences		116,439		112,609
	Dividends payable		3,435		3,435
	Accrued legal and accounting fees		92,000		84,609
	Sales tax payable		55,436		54,382
	Other		17,958		72,184
	Total	$	488,617	$	338,321

Note_K_Commitments_and_Conting1

Note K - Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block Supplement [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	Years ending December 31,
	2015	$	144,249
	2016		147,732
	2017		152,364
	2018		103,829
		$	548,174

Note_L_Equity_Tables

Note L - Equity (Tables)	12 Months Ended
	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]		Total Warrants			Weighted		Weighted		Aggregate
					average		average		intrinsic
					exercise		remaining		value
					price		life
							(in years)
	Outstanding, as of January1, 2013		4,125,000		$	0.6		2.97
	Granted		15,209,579			0.5
	Exercised		—			—
	Forfeited		—			—
	Expired		—			—
	Outstanding, as of December 31, 2013		19,334,579			0.52		2.79		—
	Granted		11,962,501			0.3
	Exercised		(150,000	)		0.2
	Forfeited		(7,974,999	)		0.5
	Expired		(125,000	)		0.6
	Repurchased		(4,000,000	)		0.6
	Vested or expected to vest at December 31, 2014		19,047,081			0.37		3.91		—
	Exercisable at December 31, 2014		13,065,816		$	0.41		3.47		—

Note_M_Stock_Options_Tables

Note M - Stock Options (Tables)	12 Months Ended
	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]		Number of Options											Weighted			Weighted			Aggregate
													average			average			intrinsic
													exercise			remaining
																life
		1999 Plan		2004 Plan			Non Plan			Total			price			(in years)			value
	Outstanding, as of December 31, 2012		250,000		1,381,136			—			1,631,136		$	0.32
	Granted		—		575,000			600,000			1,175,000			0.34
	Exercised		—		(89,999	)		—			(89,999	)		0.26
	Forfeited		—		(20,833	)		—			(20,833	)		0.32
	Expired		—		—			—			—			—
	Outstanding, as of December 31, 2013		250,000		1,845,304			600,000			2,695,304		$	0.33			4.48		$	136,787
	Granted		—		—			1,835,000			1,835,000			0.39
	Exercised		—		(54,166	)		—			(54,166	)		0.25
	Forfeited		—		(129,168	)		(225,000	)		(354,168	)		0.34
	Expired		—		(26,665	)		—			(26,665	)		0.29
	Outstanding, as of December 31, 2014		250,000		1,635,305			2,210,000			4,095,305		$	0.36			4.45		$	24,325
	Vested or expected to vest at December 31, 2014										3,385,905		$	0.36			4.06		$	24,325
	Exercisable at December 31, 2014										1,726,963		$	0.33			2.17		$	24,325
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]					Options Outstanding									Options Exercisable
	Range of exercise prices				Number of			Weighted			Weighted			Number			Weighted
					shares			average			average			exercisable			average
								exercise			remaining						exercise
								price			life (in years)						price
	$0.14 - 0.42					3,890,305		$	0.33			4.58			1,521,963		$	0.26
	0.43 - 0.80					35,000			0.8			2.02			35,000			0.8
	0.81 - 0.95					170,000			0.92			2.02			170,000			0.92
	$0.14 - 0.95					4,095,305									1,726,963

Note_N_Income_Taxes_Tables

Note N - Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]		2014			2013
	Current asset:
	Accrued compensation	$	88,000		$	49,000
	Accounts receivable allowance		8,000			8,000
	Non-current asset (liability):
	Stock-based compensation		174,000			205,000
	Basis differences in fixed assets		(26,000	)		(19,000	)
	Basis differences in intangible assets		(63,000	)		(69,000	)
	Net operating loss and credit carryforwards		17,540,000			17,217,000
	Valuation allowances		(17,721,000	)		(17,391,000	)
		$	—		$	—
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]		2014			2013
	Federal statutory income tax rate		34	%		34	%
	Permanent differences		—			(3	)
	Effect of net operating loss		(34	)		(31	)
	Effective tax rate		—	%		—	%

Note_P_Earnings_Per_Share_EPS_

Note P - Earnings Per Share (EPS) (Tables)	12 Months Ended
	Dec. 31, 2014
Earnings Per Share [Abstract]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]		Years ended December 31,
		2014		2013
	Stock options		516,214		922,265
	Warrants		2,013,491		83,345
	Potentially dilutive securities		2,529,705		1,005,610
		Years ended December 31,
		2014		2013
	Stock options		1,615,000		205,000
	Warrants		7,084,580		19,184,565
	Total		8,699,580		19,389,565

Note_A_The_Company_and_Summary2

Note A - The Company and Summary of Significant Accounting Policies (Details) (USD $)	12 Months Ended		0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Feb. 03, 2015	Dec. 31, 2012
Note A - The Company and Summary of Significant Accounting Policies (Details) [Line Items]
Retained Earnings (Accumulated Deficit)	($56,754,144)	($54,870,572)
Cash and Cash Equivalents, at Carrying Value	843,632	2,023,349		83,989
Operational Costs Per Month	475,000
Advertising Expense	252,000	178,000
Allocated Share-based Compensation Expense	$207,258	$81,642
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)	1,835,000	1,175,000
Subsequent Event [Member] | Reverse Stock Split [Member]
Note A - The Company and Summary of Significant Accounting Policies (Details) [Line Items]
Stockholders' Equity Note, Stock Split, Conversion Ratio			2
Minimum [Member]
Note A - The Company and Summary of Significant Accounting Policies (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Maximum [Member]
Note A - The Company and Summary of Significant Accounting Policies (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	4 years

Note_A_The_Company_and_Summary3

Note A - The Company and Summary of Significant Accounting Policies (Details) - Summary of Accounts Receivable (USD $)	Dec. 31, 2014	Dec. 31, 2013
Summary of Accounts Receivable [Abstract]
Accounts receivable	$645,867	$304,551
Allowance for doubtful accounts	-20,526	-20,526
Accounts receivable, net allowances for doubtful accounts	$625,341	$284,025

Note_A_The_Company_and_Summary4

Note A - The Company and Summary of Significant Accounting Policies (Details) - Allowance for Doubtful Accounts (Allowance for Doubtful Accounts [Member], USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Allowance for Doubtful Accounts [Member]
Valuation Allowance [Line Items]
Balance at beginning of year	$20,526	$20,526
Charges to costs and expenses	0	0
Deductions from reserves	0	0
Balance at end of year	$20,526	$20,526

Note_A_The_Company_and_Summary5

Note A - The Company and Summary of Significant Accounting Policies (Details) - Estimated Useful Lives for Depreciation and Amortization	12 Months Ended
	Dec. 31, 2014
Equipment [Member] | Minimum [Member]
Note A - The Company and Summary of Significant Accounting Policies (Details) - Estimated Useful Lives for Depreciation and Amortization [Line Items]
Property, Plan and Equipment	3 years
Equipment [Member] | Maximum [Member]
Note A - The Company and Summary of Significant Accounting Policies (Details) - Estimated Useful Lives for Depreciation and Amortization [Line Items]
Property, Plan and Equipment	5 years
Furniture and Fixtures [Member] | Minimum [Member]
Note A - The Company and Summary of Significant Accounting Policies (Details) - Estimated Useful Lives for Depreciation and Amortization [Line Items]
Property, Plan and Equipment	3 years
Furniture and Fixtures [Member] | Maximum [Member]
Note A - The Company and Summary of Significant Accounting Policies (Details) - Estimated Useful Lives for Depreciation and Amortization [Line Items]
Property, Plan and Equipment	5 years
Software Development [Member]
Note A - The Company and Summary of Significant Accounting Policies (Details) - Estimated Useful Lives for Depreciation and Amortization [Line Items]
Property, Plan and Equipment	3 years
Leasehold Improvements [Member]
Note A - The Company and Summary of Significant Accounting Policies (Details) - Estimated Useful Lives for Depreciation and Amortization [Line Items]
Leasehold improvements	life or lease term

Note_A_The_Company_and_Summary6

Note A - The Company and Summary of Significant Accounting Policies (Details) - Share-based Compensation Expenses for Continuing Operations (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$207,258	$81,642
Selling, General and Administrative Expenses [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	161,466	60,151
Research and Development Expense [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$45,792	$21,491

Note_A_The_Company_and_Summary7

Note A - The Company and Summary of Significant Accounting Policies (Details) - Valuation Assumptions for Stock Options	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Valuation Assumptions for Stock Options [Abstract]
Risk free interest rate	1.34%	0.68%
Expected life of options (in years)	4 years 6 months	4 years 6 months
Expected dividends	0.00%	0.00%
Volatility of stock price	119.00%	139.00%

Note_B_Factoring_Details

Note B - Factoring (Details)	12 Months Ended
	Dec. 31, 2011
Note B - Factoring (Details) [Line Items]
Factoring Arrangment, Term	24 months
Percentage of Accounts Receivable Remitted by Factor	75.00%
Minimum [Member]
Note B - Factoring (Details) [Line Items]
Factoring Fees, Percent	2.75%
Maximum [Member]
Note B - Factoring (Details) [Line Items]
Factoring Fees, Percent	15.00%

Note_B_Factoring_Details_Due_f

Note B - Factoring (Details) - Due from Factor (USD $)	Dec. 31, 2014	Dec. 31, 2013
Due from Factor [Abstract]
Original invoice value	$306,625	$9,795
Factored amount	229,968	7,346
Factored balance due	$76,657	$2,449

Note_C_Fair_Values_of_Financia2

Note C - Fair Values of Financial Instruments (Details) - Fair Value Measurement of Warrant Liabilities and Derivative Liabilities (Warrant and Derivative Liabilities [Member])	12 Months Ended
	Dec. 31, 2014
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Expected dividends	0.00%
Minimum [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Risk free interest rate	0.59%
Expected term	1 year 299 days
Volatility of stock price	79.30%
Maximum [Member]
Fair Value Inputs, Assets, Quantitative Information [Line Items]
Risk free interest rate	0.61%
Expected term	1 year 313 days
Volatility of stock price	79.70%

Note_C_Fair_Values_of_Financia3

Note C - Fair Values of Financial Instruments (Details) - Fair Value Measurements Using Significant Unobservable Inputs (USD $)	0 Months Ended
	Jan. 01, 2014	Dec. 31, 2014
Compensatory Warrant [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value	$36,370
Loss on derivative	6,227
Transfer to additional paid-in-capital	-42,597
Warrants Issued under PI SPA [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value	206,707
Loss on derivative	-163,480
Value		$43,227

Note_D_Concentration_of_Risk_D

Note D - Concentration of Risk (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Risks and Uncertainties [Abstract]
Cash, Uninsured Amount	$586,000	$1,535,000

Note_D_Concentration_of_Risk_D1

Note D - Concentration of Risk (Details) - Revenue Concentration Risk by Major Customer (Sales Revenue, Net [Member], Customer Concentration Risk [Member])	12 Months Ended
	Dec. 31, 2014		Dec. 31, 2013
Customer A [Member]
Revenue, Major Customer [Line Items]
Percentage of revenues	44.00%			[1]
Customer B [Member]
Revenue, Major Customer [Line Items]
Percentage of revenues	11.00%			[1]
Customer C [Member]
Revenue, Major Customer [Line Items]
Percentage of revenues	10.00%			[1]
Customer D [Member]
Revenue, Major Customer [Line Items]
Percentage of revenues		[1]	19.00%
Customer E [Member]
Revenue, Major Customer [Line Items]
Percentage of revenues		[1]	15.00%
[1]	Less than 10% of total revenue

Note_D_Concentration_of_Risk_D2

Note D - Concentration of Risk (Details) - Accounts Receivable Concentration Risk by Major Customer (Accounts Receivable [Member], Customer Concentration Risk [Member])	12 Months Ended
	Dec. 31, 2014		Dec. 31, 2013
Customer A [Member]
Concentration Risk [Line Items]
Percentage of accounts receivable	62.00%			[1]
Customer F [Member]
Concentration Risk [Line Items]
Percentage of accounts receivable		[1]	50.00%
[1]	Less than 10% of total accounts receivable

Note_E_Equipment_and_Leashold_2

Note E - Equipment and Leashold Improvements (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Abstract]
Depreciation, Depletion and Amortization, Nonproduction	$40,186	$28,618

Note_E_Equipment_and_Leashold_3

Note E - Equipment and Leashold Improvements (Details) - Summary of Equipment and Leasehold Improvements (USD $)	Dec. 31, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	$617,897	$599,264
Less accumulated depreciation and amortization	-514,388	-474,202
Total	103,509	125,062
Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	395,546	378,074
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	139,779	138,618
Software Development [Member]
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	28,624	28,624
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, gross	$53,948	$53,948

Note_F_Intangible_Assets_Detai

Note F - Intangible Assets (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Disclosure Text Block [Abstract]
Amortization of Intangible Assets	$13,606	$20,961
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months	14,000
Finite-Lived Intangible Assets, Amortization Expense, Year Three	14,000
Finite-Lived Intangible Assets, Amortization Expense, Year Four	14,000
Finite-Lived Intangible Assets, Amortization Expense, Year Five	14,000
Finite-Lived Intangible Assets, Amortization Expense, Year Two	14,000
Finite-Lived Intangible Assets, Amortization Expense, after Year Five	$91,000

Note_F_Intangible_Assets_Detai1

Note F - Intangible Assets (Details) - Summary of Intangible Assets (USD $)	Dec. 31, 2014	Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$287,248	$287,248
Accumulated amortization	-125,904	-112,298
Net carrying amount	161,344	174,950
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	287,248	287,248
Accumulated amortization	-125,904	-112,298
Net carrying amount	$161,344	$174,950

Note_G_Accrued_Laibilites_Deta

Note G - Accrued Laibilites (Details) - Summary of Accrued Liabilities (USD $)	Dec. 31, 2014	Dec. 31, 2013
Summary of Accrued Liabilities [Abstract]
Compensation	$203,349	$11,102
Compensated absences	116,439	112,609
Dividends payable	3,435	3,435
Accrued legal and accounting fees	92,000	84,609
Sales tax payable	55,436	54,382
Other	17,958	72,184
Total	$488,617	$338,321

Note_H_Related_Party_Details

Note H - Related Party (Details) (USD $)	24 Months Ended
	Dec. 31, 2011	Dec. 31, 2013
Monthly Payment to Mr. Colatosti [Member]
Note H - Related Party (Details) [Line Items]
Related Party Transaction, Amounts of Transaction	$5,000
Chief Financial Officer [Member]
Note H - Related Party (Details) [Line Items]
Accounts Payable, Related Parties		$50,000

Note_I_Deferred_Revenue_Detail

Note I - Deferred Revenue (Details) (Maintenance Contracts [Member], USD $)	Dec. 31, 2014	Dec. 31, 2013
Maintenance Contracts [Member]
Note I - Deferred Revenue (Details) [Line Items]
Deferred Revenue, Current	$429,000	$528,000

Note_J_Segment_Information_Det

Note J - Segment Information (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Note J - Segment Information (Details) [Line Items]
Number of Reportable Segments	1
Sales Revenue, Net [Member] | Geographic Concentration Risk [Member] | North America [Member]
Note J - Segment Information (Details) [Line Items]
Concentration Risk, Percentage	91.00%	97.00%

Note_K_Commitments_and_Conting2

Note K - Commitments and Contingencies (Details) (USD $)	12 Months Ended		0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Mar. 13, 2014
Note K - Commitments and Contingencies (Details) [Line Items]
Operating Leases, Rent Expense	$174,000	$159,000
LifeSouth [Member]
Note K - Commitments and Contingencies (Details) [Line Items]
Loss Contingency, Damages Sought, Value			$718,500

Note_K_Commitments_and_Conting3

Note K - Commitments and Contingencies (Details) - Future Minimum Rental Commitments of Non-cancelable Operating Leases (USD $)	Dec. 31, 2014
Future Minimum Rental Commitments of Non-cancelable Operating Leases [Abstract]
2015	$144,249
2016	147,732
2017	152,364
2018	103,829
	$548,174

Note_L_Equity_Details

Note L - Equity (Details) (USD $)

1 Months Ended

12 Months Ended

0 Months Ended

9 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

0 Months Ended

10 Months Ended

1 Months Ended

0 Months Ended

1 Months Ended

Jan. 27, 2014

Dec. 31, 2014

Dec. 31, 2013

Nov. 08, 2013

Mar. 10, 2014

Mar. 11, 2014

Sep. 30, 2014

Feb. 26, 2013

Nov. 13, 2014

Nov. 30, 2014

Nov. 08, 2013

Oct. 25, 2013

Jul. 23, 2013

Jan. 01, 2014

Feb. 03, 2015

Jan. 29, 2015

Dec. 31, 2012

Aug. 15, 2013

Feb. 28, 2015

Nov. 22, 2013

Note L - Equity (Details) [Line Items]

Preferred Stock, Shares Authorized

5,000,000

Preferred Stock, Par or Stated Value Per Share (in Dollars per share)

$0.00

Sale of Stock, Price Per Share (in Dollars per share)

$0.54

$0.54

Stock Issued During Period, Value, New Issues (in Dollars)

$1,595,000

$5,649,794

Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs (in Dollars)

103,157

648,116

Class of Warrant or Right, Outstanding

19,334,579

4,125,000

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$0.60

Payments of Stock Issuance Costs (in Dollars)

103,157

575,681

Embedded Derivative, Fair Value of Embedded Derivative Liability (in Dollars)

20,323

Warrants and Rights Outstanding (in Dollars)

93,639

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

4,000,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

54,166

89,999

Payments for Repurchase of Warrants (in Dollars)

150,000

150,000

Private Investor SPA [Member] | Warrant [Member]

Note L - Equity (Details) [Line Items]

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$0.50

$0.50

Private Investor SPA [Member]

Note L - Equity (Details) [Line Items]

Sale of Stock, Price Per Share (in Dollars per share)

$0.30

$0.30

Term of Warrant

3 years

Warrant Exercisable on Cashless Basis, Period following Annivesary of Issuance Date

9 months

InterDigital SPA [Member] | Contracted Compensation [Member]

Note L - Equity (Details) [Line Items]

Class of Warrant or Right, Outstanding

150,000

Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings (in Dollars)

-6,227

Stock Issued During Period, Shares, Other

76,830

Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 (in Dollars)

42,597

InterDigital SPA [Member]

Note L - Equity (Details) [Line Items]

Sale of Stock, Price Per Share (in Dollars per share)

$0.20

Stock Issued During Period, Value, New Issues (in Dollars)

402,693

Purchase Exercise or Conversion Price Per Share Threshold of Common Stock (in Dollars per share) (in Dollars per share)

$0.20

Private Investor SPA [Member] | Common Stock [Member] | Subsequent Event [Member]

Note L - Equity (Details) [Line Items]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

5,981,250

Private Investor SPA [Member] | Common Stock [Member]

Note L - Equity (Details) [Line Items]

Stock Issued During Period, Shares, New Issues

12,323,668

7,974,999

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

5,981,251

Private Investor SPA [Member] | Warrant [Member]

Note L - Equity (Details) [Line Items]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

12,323,668

12,323,668

Private Investor SPA [Member] | Rights [Member] | Minimum [Member]

Note L - Equity (Details) [Line Items]

Sale of Stock, Price Per Share (in Dollars per share)

$0.30

$0.30

Private Investor SPA [Member]

Note L - Equity (Details) [Line Items]

Sale of Stock, Price Per Share (in Dollars per share)

$0.20

Stock Issued During Period, Value, New Issues (in Dollars)

3,697,100

1,595,000

Stock Issued During Period, Shares, New Issues

12,323,668

2,500,000

Proceeds from Issuance of Private Placement (in Dollars)

500,000

Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs (in Dollars)

46,176

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

0.3

Payments of Stock Issuance Costs (in Dollars)

466,346

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

11,962,501

Term of Warrant

5 years

Warrants Cancelled

7,974,999

July Private Investor SPA [Member] | Rights [Member]

Note L - Equity (Details) [Line Items]

Sale of Stock, Price Per Share (in Dollars per share)

$0.54

Stock Issued During Period, Value, New Issues (in Dollars)

27,307

Stock Issued During Period, Shares, New Issues

178,726

July Private Investor SPA [Member]

Note L - Equity (Details) [Line Items]

Sale of Stock, Price Per Share (in Dollars per share)

$0.60

Stock Issued During Period, Value, New Issues (in Dollars)

1,050,000

Purchase Exercise or Conversion Price Per Share Threshold of Common Stock (in Dollars per share) (in Dollars per share)

$0.60

Stock Issued During Period, Shares, New Issues

1,750,003

Class of Warrant or Right, Outstanding

1,750,003

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

$0.80

$0.50

Payments of Stock Issuance Costs (in Dollars)

135,594

Warrants Issued under PI SPA [Member] | Fair Value, Inputs, Level 3 [Member]

Note L - Equity (Details) [Line Items]

Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances (in Dollars)

325,891

Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings (in Dollars)

163,480

Warrants Issued under PI SPA [Member]

Note L - Equity (Details) [Line Items]

Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances (in Dollars)

206,707

Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings (in Dollars)

163,480

Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value (in Dollars)

43,227

Placement Agent Warrants [Member] | Fair Value, Inputs, Level 3 [Member]

Note L - Equity (Details) [Line Items]

Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value (in Dollars)

43,227

206,707

Compensatory Warrant [Member] | Fair Value, Inputs, Level 3 [Member]

Note L - Equity (Details) [Line Items]

Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value (in Dollars)

36,370

Compensatory Warrant [Member]

Note L - Equity (Details) [Line Items]

Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances (in Dollars)

36,370

Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings (in Dollars)

-6,227

Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 (in Dollars)

42,597

Common Stock [Member]

Note L - Equity (Details) [Line Items]

Stock Issued During Period, Value, New Issues (in Dollars)

$797

$1,859

Stock Issued During Period, Shares, New Issues

7,974,999

18,587,139

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period

28,173

50,279

Stock Issued During Period, Shares, Other

206,033

Placement Agent Warrants [Member]

Note L - Equity (Details) [Line Items]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights

985,893

985,893

Commissions and Fees, Percent of Gross Proceeds

8.00%

8.00%

Subsequent Event [Member] | Reverse Stock Split [Member]

Note L - Equity (Details) [Line Items]

Stockholders' Equity Note, Stock Split, Conversion Ratio

2

Subsequent Event [Member]

Note L - Equity (Details) [Line Items]

Stock Issued During Period, Shares, New Issues

13,956,250

Maximum [Member]

Note L - Equity (Details) [Line Items]

Debt Instrument, Convertible, Conversion Price (in Dollars per share)

0.2

Note_L_Equity_Details_Summary_

Note L - Equity (Details) - Summary of Warrant Activity (USD $)	0 Months Ended	12 Months Ended
	Jan. 01, 2013	Dec. 31, 2014	Dec. 31, 2013
Summary of Warrant Activity [Abstract]
Total warrants	4,125,000	19,334,579	4,125,000
Weighted average exercise price	$0.60	$0.52	$0.60
Weighted average remaining life	2 years 354 days		2 years 288 days
Total warrants, granted		11,962,501	15,209,579
Weighted average exercise price, granted		$0.30	$0.50
Total warrants, exercised		-150,000
Weighted average exercise price, exercised		$0.20
Total warrants, forfeited		-7,974,999
Weighted average exercise price, forfeited		$0.50
Total warrants, expired		-125,000
Weighted average exercise price, expired		$0.60
Repurchased		-4,000,000
Repurchased		$0.60
Vested or expected to vest at December 31, 2014		19,047,081
Vested or expected to vest at December 31, 2014		$0.37
Vested or expected to vest at December 31, 2014		3 years 332 days
Exercisable at December 31, 2014		13,065,816
Exercisable at December 31, 2014		$0.41
Exercisable at December 31, 2014		3 years 171 days
Total warrants			19,334,579
Weighted average exercise price			$0.52
Weighted average remaining life	2 years 354 days		2 years 288 days

Note_M_Stock_Options_Details

Note M - Stock Options (Details) (USD $)	12 Months Ended		8 Months Ended	0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Aug. 31, 2009	Oct. 12, 2004
Note M - Stock Options (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	4 years 164 days	4 years 175 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in Shares)	1,726,963
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)	$0.32	$0.30
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value	$14,650	$31,643
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	143,382	42,058
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options	$438,571
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	1 year 339 days
Non-statutory Stock [Member] | 1999 Stock Option Plan [Member]
Note M - Stock Options (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term			10 years
In the Money Options [Member]
Note M - Stock Options (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in Shares)	550,000
Closing Stock Price [Member]
Note M - Stock Options (Details) [Line Items]
Share Price (in Dollars per share)	$0.22
Minimum [Member] | 1999 Stock Option Plan [Member]
Note M - Stock Options (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent			85.00%
Minimum [Member] | 2004 Stock Option Plan [Member]
Note M - Stock Options (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent				85.00%
1999 Stock Option Plan [Member]
Note M - Stock Options (Details) [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance (in Shares)			1,000,000
2004 Stock Option Plan [Member]
Note M - Stock Options (Details) [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance (in Shares)				2,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term				10 years

Note_M_Stock_Options_Details_O

Note M - Stock Options (Details) - Option Activity (USD $)	0 Months Ended	12 Months Ended
	Oct. 12, 2004	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Note M - Stock Options (Details) - Option Activity [Line Items]
Outstanding		4,095,305	2,695,304	1,631,136
Outstanding, weighted average exercise price (in Dollars per share)		0.36	0.33	0.32
Outstanding, weighted average remaining life		4 years 164 days	4 years 175 days
Outstanding, aggregate intrinsic value (in Dollars)		24,325	136,787
Vested or expected to vest at December 31, 2014		3,385,905
Vested or expected to vest at December 31, 2014 (in Dollars per share)		0.36
Vested or expected to vest at December 31, 2014		4 years 21 days
Vested or expected to vest at December 31, 2014 (in Dollars)		24,325
Exercisable at December 31, 2014		1,726,963
Exercisable at December 31, 2014 (in Dollars per share)		0.33
Exercisable at December 31, 2014		2 years 62 days
Exercisable at December 31, 2014 (in Dollars)		24,325
Granted		1,835,000	1,175,000
Granted, weighted average exercise price (in Dollars per share)		0.39	0.34
Exercised		-54,166	-89,999
Exercised, weighted average exercise price (in Dollars per share)		0.25	0.26
Forfeited		-354,168	-20,833
Forfeited, weighted average exercise price (in Dollars per share)		0.34	0.32
Expired		-26,665
Expired, weighted average exercise price (in Dollars per share)		0.29
1999 Stock Option Plan [Member]
Note M - Stock Options (Details) - Option Activity [Line Items]
Outstanding		250,000	250,000	250,000
2004 Stock Option Plan [Member]
Note M - Stock Options (Details) - Option Activity [Line Items]
Outstanding		1,635,305	1,845,304	1,381,136
Outstanding, weighted average remaining life	10 years
Granted			575,000
Exercised		-54,166	-89,999
Forfeited		-129,168	-20,833
Expired		-26,665
Non Plan [Member]
Note M - Stock Options (Details) - Option Activity [Line Items]
Outstanding		2,210,000	600,000
Granted		1,835,000	600,000
Forfeited		-225,000

Note_M_Stock_Options_Details_O1

Note M - Stock Options (Details) - Options Outstanding and Exercisable (USD $)	12 Months Ended
	Dec. 31, 2014
Note M - Stock Options (Details) - Options Outstanding and Exercisable [Line Items]
Options exercisable	$0.33
Exercise Price Range 1 [Member]
Note M - Stock Options (Details) - Options Outstanding and Exercisable [Line Items]
Range of exercise prices,lower range	$0.14
Range of exercise prices, upper range	$0.42
Options outstanding (in Shares)	3,890,305
Options outstanding, weighted average exercise price	$0.33
Options outstanding, weighted average remaining life	4 years 211 days
Options exercisable	$1,521,963
Options exercisable, weighted average exercise price (in Shares)	0.26
Exercise Price Range 2 [Member]
Note M - Stock Options (Details) - Options Outstanding and Exercisable [Line Items]
Range of exercise prices,lower range	$0.43
Range of exercise prices, upper range	$0.80
Options outstanding (in Shares)	35,000
Options outstanding, weighted average exercise price	$0.80
Options outstanding, weighted average remaining life	2 years 7 days
Options exercisable	$35,000
Options exercisable, weighted average exercise price (in Shares)	0.8
Exercise Price Range 3 [Member]
Note M - Stock Options (Details) - Options Outstanding and Exercisable [Line Items]
Range of exercise prices,lower range	$0.81
Range of exercise prices, upper range	$0.95
Options outstanding (in Shares)	170,000
Options outstanding, weighted average exercise price	$0.92
Options outstanding, weighted average remaining life	2 years 7 days
Options exercisable	$170,000
Options exercisable, weighted average exercise price (in Shares)	0.92
Exercise Price Range 4 [Member]
Note M - Stock Options (Details) - Options Outstanding and Exercisable [Line Items]
Range of exercise prices,lower range	$0.14
Range of exercise prices, upper range	$0.95
Options outstanding (in Shares)	4,095,305
Options exercisable	$1,726,963

Note_N_Income_Taxes_Details

Note N - Income Taxes (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Note N - Income Taxes (Details) [Line Items]
Income Tax Expense (Benefit)	$1,712	$2,805
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	0	0
Earliest Tax Year [Member]
Note N - Income Taxes (Details) [Line Items]
Open Tax Year	2011
Latest Tax Year [Member]
Note N - Income Taxes (Details) [Line Items]
Open Tax Year	2014
Domestic Tax Authority [Member]
Note N - Income Taxes (Details) [Line Items]
Income Tax Expense (Benefit)	0
Operating Loss Carryforwards	49,200,000
State and Local Jurisdiction [Member]
Note N - Income Taxes (Details) [Line Items]
Income Tax Expense (Benefit)	$0

Note_N_Income_Taxes_Details_Co

Note N - Income Taxes (Details) - Components of Deferred Taxes (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current asset:
Accrued compensation	$88,000	$49,000
Accounts receivable allowance	8,000	8,000
Stock-based compensation	174,000	205,000
Basis differences in fixed assets	-26,000	-19,000
Basis differences in intangible assets	-63,000	-69,000
Net operating loss and credit carryforwards	17,540,000	17,217,000
Valuation allowances	-17,721,000	-17,391,000
	$0	$0

Note_N_Income_Taxes_Details_Re

Note N - Income Taxes (Details) - Reconciliation of the Effective Income Tax Rate to US Federal Statutory Income Tax Rate	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Reconciliation of the Effective Income Tax Rate to US Federal Statutory Income Tax Rate [Abstract]
Federal statutory income tax rate	34.00%	34.00%
Permanent differences		-3.00%
Effect of net operating loss	-34.00%	-31.00%
Effective tax rate	0.00%	0.00%

Note_O_Profit_Sharing_Plan_Det

Note O - Profit Sharing Plan (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Compensation and Retirement Disclosure [Abstract]
Defined Contribution Plan, Employer Discretionary Contribution Amount	$0	$0

Note_P_Earnings_Per_Share_EPS_1

Note P - Earnings Per Share (EPS) (Details) - Securities Excluded from the Diluted Per Share Calculation	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Equity Option [Member] | Exercise Price Less Than Market Price of Common Shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive Securities	516,214	922,265
Equity Option [Member] | Exercise Price Greater Than Average Market Price of Common Shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive Securities	1,615,000	205,000
Warrant [Member] | Exercise Price Less Than Market Price of Common Shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive Securities	2,013,491	83,345
Warrant [Member] | Exercise Price Greater Than Average Market Price of Common Shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive Securities	7,084,580	19,184,565
Exercise Price Less Than Market Price of Common Shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive Securities	2,529,705	1,005,610
Exercise Price Greater Than Average Market Price of Common Shares [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive Securities	8,699,580	19,389,565